Ultrasonic system
By designing the ultrasound array and cooling module of the ultrasound system, the shortcomings of existing medical devices in terms of energy transmission and image acquisition are solved, enabling efficient diagnosis and treatment of patient tissues and improving the accuracy and safety of diagnosis and treatment.
Patent Information
- Application Number
- CN202580029363.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-12-18
- Filing Date
- 2025-02-21
- Publication Date
- 2026-11-17
AI Technical Summary
There is room for improvement in the systems and methods of existing medical devices for transmitting energy to diagnose or treat patient diseases and conditions, particularly in the delivery of ultrasound energy and the acquisition of image data.
An ultrasound system was designed, comprising an ultrasound array capable of operating within a specific frequency range, controlling the plate displacement ratio, generating ultrasound waves at specific pressures and frequencies, and equipped with a cooling module to reduce heat buildup. The system also enables real-time monitoring of image data and tracking of treatment progress, including precise localization of target tissues and determination of treatment parameters.
It enables efficient diagnosis and treatment of patient tissues, reduces damage to non-target tissues, improves the accuracy and safety of diagnosis and treatment, and provides real-time monitoring and feedback on treatment progress.
Smart Images

Figure CN123124937A_ABST
Abstract
Description
[0001] Related applications This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 556,111 (USD-011-PR1), filed February 21, 2024, entitled “Ultrasound System,” the contents of which are incorporated herein by reference in their entirety for all purposes.
[0002] This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 735,560 (USD-011-PR2), filed December 18, 2024, entitled “Ultrasound System,” the contents of which are incorporated herein by reference in their entirety for all purposes.
[0003] This application relates to U.S. Provisional Application Serial No. 62 / 728,616 (USD-001-PR), filed September 7, 2018, entitled “Medical Device with CMUT Array and Solid State Cooling, and Associated Methods and Systems - with Thermal Analysis,” the contents of which are incorporated herein by reference in their entirety for all purposes.
[0004] This application relates to the international PCT patent application serial number PCT / US2018 / 050943 (case number USD-001-PCT) filed on September 13, 2018, entitled “Medical Device with CMUT Array and Solid State Cooling, and Associated Methods and Systems” (publication number WO 2019 / 055699, publication date March 21, 2019), the contents of which are incorporated herein by reference in their entirety for all purposes.
[0005] This application relates to U.S. Application Serial No. 16 / 130,896 (USD-001-US), filed September 13, 2018, entitled “Medical Device with CMUT Array and Solid State Cooling, and Associated Methods and Systems” (U.S. Patent No. 11,154,730, granted October 26, 2021), the contents of which are incorporated herein by reference in their entirety for all purposes.
[0006] This application relates to U.S. Patent Application Serial No. 17 / 479,011 (USD-001-US-CON1), filed September 20, 2021, entitled “Medical Device with CMUT Array and Solid State Cooling, And Associated Methods and Systems” (U.S. Patent No. 11,998,766, Grant Date June 4, 2024), the contents of which are incorporated herein by reference in their entirety for all purposes.
[0007] This application relates to U.S. Patent Application Serial No. 18 / 640,305 (USD-001-US-CON2), filed April 19, 2024, entitled “Medical Device with CMUT Array and Solid State Cooling, And Associated Methods and Systems” (U.S. Publication No. US 2024-0285980, Publication Date August 24, 2024), the contents of which are incorporated herein by reference in their entirety for all purposes.
[0008] This application relates to U.S. Provisional Patent Application Serial No. 63 / 126,078 (USD-003-PR1), filed on December 16, 2020, entitled “Tissue Interface System,” the contents of which are incorporated herein by reference in their entirety for all purposes.
[0009] This application relates to U.S. Application Serial No. 18 / 039,978 (US Patent Application No. USD-003-US), filed June 2, 2023, entitled “Tissue Interface System” (US Publication No. US 2023 / 0414299, Publication Date December 28, 2023), the contents of which are incorporated herein by reference in their entirety for all purposes.
[0010] This application relates to the international PCT patent application serial number PCT / US2021 / 063743 (case number USD-003-PCT) filed on December 16, 2021, entitled “Tissue Interface System”, the contents of which are incorporated herein by reference in their entirety for all purposes.
[0011] This application relates to U.S. Provisional Patent Application Serial No. 63 / 195,292 (USD-004-PR1), filed June 1, 2021, entitled “Tissue Treatment System,” the contents of which are incorporated herein by reference in their entirety for all purposes.
[0012] This application relates to the international PCT patent application serial number PCT / US22 / 031746 (case number USD-004-PCT) entitled “Tissue Treatment System” filed on June 1, 2022 (publication number WO2022 / 256388, publication date December 8, 2022), the contents of which are incorporated herein by reference in their entirety for all purposes.
[0013] This application relates to U.S. Application Serial No. 18 / 564,181 (USD-004-US) entitled “Tissue Treatment System”, filed November 27, 2023 (U.S. Publication No. 2024-0252845, Publication Date August 1, 2024), the contents of which are incorporated herein by reference in their entirety for all purposes.
[0014] This application relates to U.S. Provisional Patent Application Serial No. 63 / 286,161 (USD-008-PR1), filed on December 6, 2021, entitled “Capacitive Micromachined Ultrasonic Transducer,” the contents of which are incorporated herein by reference in their entirety for all purposes.
[0015] This application relates to the international PCT patent application serial number PCT / US22 / 051937 (case number USD-008-PCT) filed on December 6, 2022, entitled “Capacitive Micromachined Ultrasonic Transducer”, the contents of which are incorporated herein by reference in their entirety for all purposes.
[0016] This application relates to U.S. Application Serial No. 18 / 714,768 (US Patent No. USD-008-US) filed on May 30, 2024, entitled “Capacitive Micromachined Ultrasonic Transducer”, the contents of which are incorporated herein by reference in their entirety for all purposes.
[0017] This application relates to U.S. Provisional Patent Application Serial No. 63 / 450,490 (USD-010-PR1), filed March 7, 2023, entitled “Capacitive Micromachined Ultrasonic Transducer and Manufacturing Methods Thereof,” the contents of which are incorporated herein by reference in their entirety for all purposes.
[0018] This application relates to the international PCT patent application serial number PCT / US24 / 018763 (case number USD-010-PCT) filed on March 7, 2024, entitled “Capacitive Micromachined Ultrasonic Transducer and Manufacturing Methods Thereof”, the contents of which are incorporated herein by reference in their entirety for all purposes.
[0019] This application relates to U.S. Provisional Patent Application Serial No. 63 / 662,451 (USD-012-PR1), filed June 21, 2024, entitled “Robotically Manipulated Tissue Treatment System,” the contents of which are incorporated herein by reference in their entirety for all purposes. Technical Field
[0020] The present invention generally relates to systems, apparatus and methods for performing medical procedures on patients, particularly systems for delivering ultrasound energy to perform diagnostic and / or therapeutic procedures on patients. Background Technology
[0021] Many medical devices involve delivering energy into a patient's body to collect imaging data or treat tissue. There is a need for improved systems, devices, and methods for delivering energy to diagnose or treat patient diseases and conditions. Summary of the Invention
[0022] According to one aspect of the invention, a system for performing medical procedures on a patient includes an ultrasound device comprising an ultrasound array including one or more ultrasound transducers. The ultrasound array can be configured to emit ultrasound toward a target tissue of the patient. The system can be configured to operate the ultrasound array at a fractional bandwidth of 65% to 100% (e.g., at least 65%, no more than 100%, or both) and at a ratio of no more than 150% of the maximum plate displacement to the median plate displacement. Alternatively or additionally, the system can be configured to: operate the ultrasound array at 80% to 100% (e.g., at least 80%, no more than 100%, or both) of the center frequency of one or more ultrasound transducers during the delivery of therapeutic energy; and operate the ultrasound array at 80% to 160% (e.g., at least 80%, no more than 160%, or both) of the center frequency of one or more ultrasound transducers during the delivery of energy to generate image data.
[0023] In some embodiments, the system is configured to perform harmonic imaging at a transmit frequency of about 4 MHz and a receive frequency of about 8 MHz during the delivery of energy to generate image data.
[0024] In some embodiments, the system is configured to operate the ultrasonic array at a ratio not exceeding 150% of the maximum plate displacement to the median plate displacement.
[0025] In some embodiments, the ultrasonic array is configured to generate a surface pressure of at least 1 MPa peak-to-peak value over a time period of at least 15, 20, or 30 minutes. The ultrasonic array may operate at a frequency of at least 3 MHz, not exceeding 7 MHz, or both. The ultrasonic array may operate with an AC+DC transmit voltage not exceeding 220 V. The ultrasonic array may operate with at least 65% fractional bandwidth.
[0026] In some embodiments, the medical procedure includes a diagnostic procedure. The diagnostic procedure may include imaging and / or other diagnostic analysis of the patient's prostate. The diagnostic procedure may include imaging and / or other diagnostic analysis of the patient's anatomical location, selected from the group consisting of: prostate; uterus; nasal passages and / or tongue; organs such as bladder, bone, brain, heart, intestines, kidneys, liver, lungs, skin, and / or stomach; and combinations thereof. The diagnostic procedure may include imaging and / or other diagnostic analysis of tissue types, selected from the group consisting of: benign prostatic hyperplasia tissue; tumor tissue; tissue associated with arrhythmias; tissue associated with sleep apnea and / or airway obstruction; abnormal and / or other undesirable tissue; and combinations thereof.
[0027] In some embodiments, the medical procedure includes a treatment procedure. The treatment procedure may include ablation, stimulation, and / or other treatment of a target tissue, which may include the patient's prostate tissue. The system may be configured to avoid damaging non-target tissues of the patient. Non-target tissues may include: urethral wall tissue, seminal vesicle tissue, and / or ejaculatory duct tissue. The treatment procedure may include ablation, stimulation, and / or other treatment of a target tissue, which may include tissue located at an anatomical location selected from the group consisting of: prostate; uterus; nasal passages and / or tongue (e.g., to treat sleep apnea); organs such as bladder, bone, brain, heart, intestine, kidney, liver, lung, skin, and / or stomach; and combinations thereof. The treatment procedure may include ablation, stimulation, and / or other treatment of a target tissue, which may include tissue types selected from the group consisting of: benign prostatic hyperplasia tissue; tumor tissue; tissue associated with arrhythmias; tissue associated with sleep apnea and / or airway obstruction; other abnormal and / or other undesirable tissues; and combinations thereof. The treatment procedure may include delivering ultrasound energy to activate drugs and / or other agents; and / or enhance the efficacy of drugs and / or other agents.
[0028] In some embodiments, the system is configured to perform medical procedures including delivering ultrasound energy to an implant and / or a drug, such as powering the implant and / or a drug and / or otherwise modifying the implant and / or a drug.
[0029] In some embodiments, the medical procedure includes diagnostic and therapeutic procedures. The medical procedure may include diagnosis and treatment of a patient's prostate. The therapeutic procedure may include ablation, stimulation, and / or other treatment of a target tissue, and the target tissue may include tissue located at an anatomical location selected from the group consisting of: the prostate; the uterus; the nasal passages and / or tongue (e.g., to treat sleep apnea); organs such as the bladder, bone, brain, heart, intestines, kidneys, liver, lungs, skin, and / or stomach; and combinations thereof. The therapeutic procedure may include ablation, stimulation, and / or other treatment of the target tissue. The therapeutic procedure may include an ultrasound-enhanced local drug delivery procedure. The target tissue may include tissue types selected from the group consisting of: benign prostatic hyperplasia tissue; tumor tissue; tissue associated with arrhythmias; tissue associated with sleep apnea and / or airway obstruction; other abnormal and / or other undesirable tissue; and combinations thereof. The medical procedure may include both imaging and treatment. The imaging and treatment may be performed simultaneously, sequentially, or both. The imaging may be configured to generate image data, and the treatment may be performed based on one or more treatment parameters determined according to the generated image data. The system can determine one or more treatment parameters.
[0030] In some embodiments, the target tissue includes the patient's prostate tissue.
[0031] In some embodiments, the target tissue includes tissue located at an anatomical location selected from the group consisting of: the prostate; the uterus; the nasal passages and / or the tongue; organs such as the bladder, bones, brain, heart, intestines, kidneys, liver, lungs, skin, and / or stomach; and combinations thereof.
[0032] In some embodiments, the target tissue includes tissue having a tissue type selected from the group consisting of: benign prostatic hyperplasia tissue; tumor tissue; tissue associated with arrhythmia; tissue associated with sleep apnea and / or airway obstruction; other abnormal and / or other undesirable tissue; and combinations thereof.
[0033] In some embodiments, the system is configured to perform system diagnostic procedures, such as diagnostic procedures that evaluate the functionality of one or more ultrasonic transducers. The ultrasonic device may include a wall (e.g., an outer wall), and the evaluation may be based on ultrasonic reflections received from the wall.
[0034] In some embodiments, the system is configured to determine an orientation angle of an ultrasonic array relative to a portion of an ultrasonic device. The ultrasonic device may include a wall (e.g., an outer wall), and the orientation angle may be determined based on ultrasonic reflections received from the wall. The system may be configured to generate a 3D image, and the 3D image may be enhanced based on the determined orientation angle.
[0035] In some embodiments, the ultrasound device includes a distal portion, and the system is configured and arranged to allow an operator to perform an insertion procedure in which the distal portion of the ultrasound device is inserted into the patient, and when the insertion procedure is completed, the ultrasound array is positioned at a desired distance from the target tissue. The system may be configured to generate one or more images of the patient tissue prior to the completion of the insertion procedure, and the ultrasound array may be positioned at the desired distance based on these one or more images.
[0036] In some embodiments, the system is configured to generate one or more multidimensional images of a tissue, each multidimensional image including at least a partial circumferential image of the tissue representing a tissue sector of at least 180°. The system can be configured to create the one or more multidimensional images by manually rotating the ultrasound device by an operator. The sector may include a sector of at least 350°. The system can be configured to analyze the one or more multidimensional images and generate at least tissue volume information. The system can be configured to perform diagnostic and / or treatment planning based on the one or more multidimensional images. The one or more multidimensional images may include images of a majority of a patient's prostate, and the multidimensional images may be based on ultrasound reflections received when the ultrasound array is positioned within the prostatic urethra. The ultrasound device may include one or more flexible segments configured to reduce forces encountered during translation within the prostatic urethra or other patient conduits, and the ultrasound device may include one or more components with sufficient torsional strength to allow smooth rotation of the ultrasound array within the prostatic urethra or other patient conduits. The ultrasonic array may include a first array and a second array connected by a mechanical component, and the mechanical component may be configured to switch between a first state and a second state, in which the first array and the second array are flexibly connected, and in the second state, the first array and the second array are rigidly connected. The mechanical component may include a shape memory component and / or a mechanical linkage.
[0037] In some embodiments, the system is configured to: automatically identify one or more tissue markers; and / or allow an operator to manually identify one or more tissue markers, and the marker identification is used for: automatically positioning and / or repositioning the ultrasound array; and / or allowing an operator to manually position and / or reposition the ultrasound array. Tissue markers may include the verumontanum. The system may be configured to continuously and / or intermittently image tissue during treatment performed using an ultrasound device, for example, to track treatment progress and / or ensure the ultrasound array is in the appropriate position during treatment. The system may be configured to track treatment progress and / or ensure the ultrasound array is in the appropriate position during treatment by monitoring changes in the tissue being treated.
[0038] In some embodiments, the ultrasound device includes a distal portion configured for insertion through the urethra, and the system is configured to image the location of bladder tissue and / or within the bladder.
[0039] In some embodiments, another component of the ultrasound device and / or system is configured to perform a biopsy procedure on a patient.
[0040] In some embodiments, the ultrasound device includes a distal portion configured for insertion through a body cavity, and the system is configured to create a set of one or more images during and / or after insertion through the body cavity, and to optimize the set of one or more images. The system may be configured to perform optimization using harmonic imaging. The body cavity may include the prostatic urethra.
[0041] In some embodiments, the system is configured to determine one or more tissue characteristics. The system may be configured to determine tissue characteristics based on the attenuation of ultrasound delivered by an ultrasound array. The system may be configured to use the determined tissue characteristics to: predict the efficacy of ablation, stimulation, and / or other tissue treatments; determine ultrasound delivery parameters for performing ablation, stimulation, and / or other tissue treatments; and / or calibrate imaging-related, energy delivery-related, and / or other components of the system.
[0042] In some embodiments, the ultrasound device is configured to deliver ultrasound to treat a patient, and the system is configured to monitor the progress of treatment. The treatment may include tissue ablation, tissue stimulation, and / or other tissue treatments. The system may be configured to perform monitoring of treatment progress by simulating heat propagation generated by ultrasound delivery. The system may be configured to simulate heat propagation based on: ultrasound delivery parameters; parameters of the ultrasound device; and / or parameters of tissue and other materials near the ultrasound array during ultrasound delivery. The system may be configured to simulate heat propagation based on measurements of tissue attenuation using ultrasound images generated by the system. The system may be configured to measure tissue attenuation by analyzing the relationship between signal-to-noise ratio and depth. This analysis may include analysis of data acquired before and during the delivery of therapeutic ultrasound energy. The system may also be configured to provide confidence ranges related to monitoring treatment progress. When monitoring treatment, the system may be configured to consider one or more properties of the tissue or other tissue-related changes, such as one or more tissue-related properties selected from the group consisting of: absorption; perfusion; backscattering; temperature; elasticity; displacement (e.g., caused by energy delivery); intensity distribution; other tissue properties that may change during treatment; and combinations thereof. This system can be configured to monitor one or more parameters of an ultrasound transducer, and can be configured to monitor treatment progress based on these transducer parameters. The system can be configured to collect image data, and can be configured to monitor treatment progress based on the collected image data. The system can use local image intensity statistics techniques to assess tissue changes over time. The collected image data can include images acquired before, during, and after treatment. The local image intensity statistics techniques can include extracting local image statistics. These local image statistics can include: local mean; local standard deviation; local extrema; local kurtosis; local skewness; and / or local higher-order normalized moments. The image intensity statistics techniques can include: principal component analysis; singular value decomposition; and / or other feature extraction and / or selection techniques. Monitoring of treatment can include: capturing a first set of one or more images before treatment; capturing a second set of one or more images after treatment; and combining and / or comparing the first set of one or more images with the second set of one or more images. The system can be configured to generate visual output, wherein tissue properties representing treatment effects can be highlighted, color-coded, segmented, and / or otherwise graphically distinguished.
[0043] In some embodiments, the system is configured to perform a treatment procedure including the delivery of ultrasound, and the system is also configured to generate a treatment log representing treatment parameters and / or treatment outcomes. The treatment log may include a comparison of the tissue to be treated with the tissue actually treated. The system may be configured to generate the treatment log before the treatment procedure is completed. The treatment log may include analysis of: pressure zone; ablated tissue volume; ablated tissue volume relative to the total tissue volume; stimulated tissue volume; and / or stimulated tissue volume relative to the total tissue volume.
[0044] In some embodiments, the ultrasound device includes a catheter device.
[0045] In some embodiments, the ultrasound device includes one, two, three or more devices selected from the group consisting of: catheter devices; surgical devices; devices configured for insertion via a laparoscopic guide; devices configured for insertion via a vascular guide; devices configured for insertion via an endoscope; devices configured for insertion via a surgical incision; and combinations thereof.
[0046] In some embodiments, the ultrasound device includes a distal portion configured and arranged to be inserted into and / or pass through the patient's urethra.
[0047] In some embodiments, the ultrasound device includes a distal portion configured to be inserted into and / or pass through one or more lumens, openings, and / or other body tubes selected from the group consisting of: urethra; vaginal canal; blood vessel; catheter; airway; intestine; larynx; esophagus; oral cavity; anus; ear; nostril; and combinations thereof.
[0048] In some embodiments, the ultrasonic device further includes a thermal insulation layer surrounding at least a portion of the ultrasonic array.
[0049] In some embodiments, the ultrasound device includes an expandable anchoring element configured to anchor an ultrasound array relative to target tissue. The expandable anchoring element may include an inflatable balloon. The expandable anchoring element may be configured to expand within a patient's bladder. The ultrasound device may include a removable sleeve, and the removable sleeve may include the expandable anchoring element. The removable sleeve may include a thermal insulation layer.
[0050] In some embodiments, the ultrasound device includes a rigid segment and one or more flexible segments.
[0051] In some embodiments, the ultrasound device includes a proximal portion, a distal portion, and a lumen extending from the proximal portion to the distal portion. The lumen may be configured and arranged to slidably receive an elongated device including a diagnostic device, a therapeutic device, or both. The elongated device may include a cystoscope and / or a photoacoustic device. The system may be configured to deliver fluid through the lumen to achieve and / or enhance acoustic coupling between the ultrasound array and target tissue. The system may be configured to deliver fluid through the lumen to cool at least the ultrasound array.
[0052] In some embodiments, the ultrasound device includes a proximal portion and a lumen extending from the proximal portion, and the delivery of fluid into the lumen is configured to perform a function selected from the group consisting of: achieving and / or enhancing acoustic coupling between the ultrasound array and the target tissue; changing the flexibility of the ultrasound device; changing the straightness of the ultrasound device; and combinations thereof.
[0053] In some embodiments, the system is configured to reduce the clamping force applied to the ultrasonic device. The system may be configured to reduce the clamping force by: delivering one or more ultrasonic pulses; causing one or more portions of the ultrasonic device to vibrate; or both.
[0054] In some embodiments, the ultrasound device is configured to deliver at least 100 W / cm. 2 The energy is used to treat prostate tissue, tumor tissue, and / or other tissues.
[0055] In some embodiments, the system may further include a guide device configured to be inserted into the patient and slidably receive an ultrasound device.
[0056] In some embodiments, the ultrasound device is configured to be introduced into the lumen via a device selected from the group consisting of: a guide catheter; a Freel catheter; a sheath; a laparoscopic port; an endoscope; and combinations thereof.
[0057] In some embodiments, the ultrasound device is configured to be inserted via a means configured to be inserted through the bulbar urethra.
[0058] In some embodiments, the ultrasound device includes a vibrating element configured to reduce the insertion force encountered when the ultrasound device is translated through the patient's body tube.
[0059] In some embodiments, the ultrasonic device includes a distal portion comprising a coating. The coating may include PTFE and / or other friction-reducing coatings.
[0060] In some embodiments, the one or more ultrasonic transducers include one or more CMUT transducers.
[0061] In some embodiments, the one or more ultrasonic transducers include one or more piezoelectric transducers.
[0062] In some embodiments, the one or more ultrasonic transducers include one or more CMUT transducers and one or more piezoelectric transducers.
[0063] In some embodiments, the system includes one or more protection diodes configured to prevent damage to one or more ultrasonic transducers. Each of the one or more protection diodes may have an adjustable voltage limit. The one or more protection diodes may be configured to provide high-voltage spike protection to the one or more ultrasonic transducers. The one or more protection diodes may be configured to provide high-voltage spike protection to prevent cascade breakdown of the one or more ultrasonic transducers. The system may include a feedback control system that modifies the amplitude output and / or phase output of the one or more ultrasonic transducers.
[0064] In some embodiments, the ultrasound array includes multiple ultrasound arrays, each including one or more ultrasound transducers. The multiple ultrasound arrays may be configured and arranged to ablate, stimulate, and / or otherwise treat tissue volumes of at least 10 cc, such as at least 20 cc, 40 cc, 80 cc, 120 cc, and / or 150 cc. The ultrasound device may be configured to guide and deliver therapeutic energy to the tissue using images provided by the ultrasound device. The system may be configured to deliver energy (e.g., ablation energy) from the prostatic urethra. The multiple arrays may be configured to independently create images of the patient, and the created images may be used to provide: guidance information; diagnostic information; and / or treatment planning information. The system also includes a set of electrical connections and a multiplexer, and the multiplexer may be configured to selectively connect electrical connections to each of the multiple ultrasound arrays. A first ultrasound array may be configured to emit ultrasound, and a second ultrasound array may be configured to receive the emitted ultrasound, and the received ultrasound may be used to detect and / or measure the relative position between the first and second ultrasound arrays. The first and second ultrasound arrays may each comprise an array of at least 128 CMUT ultrasound transducers. The relative position between the first and second ultrasound arrays can be used to determine a delay, which can be used to create an image using both the first and second ultrasound arrays. The relative position between the first and second ultrasound arrays can be used to determine a delay, which can be used to deliver ultrasound energy (e.g., ablation energy, stimulation energy, or both) to the tissue using both the first and second ultrasound arrays.
[0065] In some embodiments, each of one or more ultrasound transducers in the ultrasound array is configured to switch between imaging and treatment modes (e.g., ablation, stimulation, and / or other treatment modes) in less than 6 seconds, 100 milliseconds, 10 milliseconds, and / or 1 millisecond. The system may include a switching assembly configured to perform switching of the ultrasound transducers between imaging and treatment modes. The switching assembly may include a switch with a resistance not exceeding 3 ohms per channel and a capacitance not exceeding 50 pF per channel, or both. The switching assembly may include imaging drive circuitry, treatment energy drive circuitry (e.g., ablation drive circuitry, stimulation drive circuitry, and / or other treatment energy drive circuitry), and a set of switches configured to switch between connecting one or more ultrasound transducers to the imaging drive circuitry and the treatment energy drive circuitry. The set of switches may include MEMS switches and / or low-resistance, low-capacitance switches. The imaging drive circuitry may include a set of receiver amplifiers, and the receiver amplifiers may be positioned proximal to and adjacent to each switch in the set of switches. The switching assembly may further include a set of biasers, each biaser positioned distal to each switch in the set of switches and configured to provide a DC bias to the associated ultrasound transducer. The switching assembly may include adjustable overvoltage protection circuitry. The therapeutic energy drive circuitry may include overshoot protection circuitry. The set of switches may include a corresponding set of pull-down resistors, each resistor having a resistance of at least 5 kOhm and / or at least 1 MOhm, and configured to dissipate unwanted voltages present at each switch. The switching assembly may be configured to operatively connect and disconnect each ultrasound element from a bias voltage source. The switching assembly may be configured to test for short circuits by connecting the ultrasound element to the bias voltage source and measuring the current delivered by the bias voltage source.
[0066] In some embodiments, the ultrasonic transducers of the ultrasonic array are arranged for both forward-looking and side-looking configurations.
[0067] In some embodiments, the ultrasonic device further includes an acoustic lens.
[0068] In some embodiments, the ultrasound device further includes a handle. The system also includes a user interface, and the handle may include at least a portion of the user interface. The handle may include an alarm element containing a tactile transducer.
[0069] In some embodiments, the ultrasound device further includes a cooling module. The cooling module may be mechanically coupled to the ultrasound array and / or otherwise positioned in the vicinity of the ultrasound array. The cooling module may be configured to cool the ultrasound array, the tissue in the vicinity of the ultrasound array, and / or the tissue being treated, or both. The cooling module may include a thermoelectric cooling module. The cooling module may include a solid-state cooling module. The cooling module may include a cooling element and a solid heat conductor configured to conduct heat away from the cooling element. The cooling module may include a fluid path that can be positioned within the ultrasound device.
[0070] In some embodiments, the ultrasound device includes a sensor module comprising one or more sensors. The one or more sensors may include one or more temperature sensors. The one or more sensors may include one or more sensors selected from the group consisting of: temperature sensors; pressure sensors; strain gauges; accelerometers; gyroscopes; inertial measurement units (IMUs); physiological sensors; GPS sensors; and combinations thereof. The sensor module may be configured to record parameters of target tissue and / or non-target tissue. The non-target tissue parameters may include parameters selected from the group consisting of: temperature; pressure; and combinations thereof. The sensor module may include at least one sensor configured for articulation. The at least one articulated sensor may be configured to rotate and record data while avoiding applying force to tissue near the at least one articulated sensor.
[0071] In some embodiments, the system includes a console comprising an ultrasound module for providing drive signals to an ultrasound array. The ultrasound module may include a dual-frequency signal generator. The ultrasound module may be configured to generate a drive signal of a first frequency for delivering ultrasound to tissue at a distance not exceeding D1 from the ultrasound array, and to generate a drive signal of a second frequency for delivering ultrasound to target tissue at a distance of at least D2 from the ultrasound array, where D2 may be equal to or greater than D1, and the first frequency may be higher than the second frequency. The first frequency may include a frequency of at least 4.5 MHz, and the second frequency may include a frequency not exceeding 3.5 MHz, where D1 may include a distance not exceeding 25 mm, and D2 may include a distance of at least 25 mm. The first frequency may include a frequency not exceeding 5.5 MHz and / or the second frequency may include a frequency of at least 2.5 MHz. D1 may include a distance of at least 0.001 mm, and D2 may include a distance not exceeding 50 mm. The ultrasound module may include tuning circuitry operating at one or more frequencies of at least 1 MHz and / or one or more frequencies not exceeding 10 MHz. The ultrasound module may include two electronically switchable tuning circuits configured to provide operation at multiple different frequencies. The ultrasound module may include relays and / or other switching components configured to switch between components of two electronically switchable tuning circuits. One or more components of a first tuning circuit of the two electronically switchable tuning circuits may be shared by a second tuning circuit of the two electronically switchable tuning circuits. The ultrasound module may be configured to operate a first group of one or more transducers of an ultrasound array at a first frequency and simultaneously operate a second group of one or more transducers of the ultrasound array at a second frequency different from the first frequency.
[0072] In some embodiments, the ultrasound device includes an identification component, and the console is configured to receive information from the identification component. The identification component may include RFID. The information received from the identification component may include diagnostic information, calibration information, and / or manufacturing information of the ultrasound device. The information received from the identification component may be used by the console to confirm that the ultrasound device is correctly instructed, correctly configured, and / or otherwise ready for use.
[0073] In some embodiments, the system includes a cooling device. The ultrasound device may include a cooling module configured and arranged to receive cooling fluid supplied by the cooling device. The cooling module may include one or more fluid paths that can be located within the ultrasound device and receive cooling fluid supplied by the cooling device.
[0074] In some embodiments, the system may further include a processing unit comprising a processor and a memory storage element coupled to the processor, the memory storage element storing instructions for the processor to execute algorithms. The system also includes a console, which may include at least a portion of the processing unit. The ultrasound device may include at least a portion of the processing unit. The algorithm may include an artificial intelligence algorithm. The system may be configured to generate multidimensional images of tissue, and the algorithm may include an artificial intelligence algorithm or other algorithms configured to: identify tissue areas to be avoided for treatment; and / or suggest tissue areas to be treated. The algorithm may include an artificial intelligence algorithm or other algorithms configured to evaluate image data to maintain a focal spot for delivering therapeutic energy (e.g., ablation energy, stimulation energy, and / or other therapeutic energy). The algorithm may be configured to modify the delay of signals delivered to the ultrasound transducer to maintain the focal spot. The algorithm may include an artificial intelligence algorithm or other algorithms configured to identify one or more therapeutic energy delivery patterns (e.g., ablation patterns) that reduce edema or other undesirable effects when delivering ablation or other therapeutic energy to target tissue. The processing unit may also include at least one application configured to be provided and / or executed by the system.
[0075] In some embodiments, the system includes a user interface. The system also includes a console, and the console may include at least a portion of the user interface. The ultrasound device may include at least a portion of the user interface. The user interface may include an alarm element. The alarm element may include a tactile transducer positioned within the ultrasound device. The user interface may include a touchscreen display and / or other displays. The user interface may be configured as a graphical user interface.
[0076] In some embodiments, the system may further include one or more functional elements. These functional elements may include one or more sensors and / or one or more transducers. The functional elements may include one or more vacuum ports located near the ultrasound array. These one or more vacuum ports may be configured to: prevent movement of the ultrasound array; maintain a portion of the ultrasound device in contact with tissue; or both.
[0077] In some embodiments, the system may further include a robotic manipulator configured to robotically manipulate the ultrasound device and / or one or more other components of the system. The robotic manipulator may be configured to rotate the ultrasound device to create 360° images of the tissue and / or images of the tissue at least greater than 180°.
[0078] In some embodiments, the system may also include a pharmaceutical agent comprising one or more agents.
[0079] In some embodiments, the system may also include a network and at least one server.
[0080] In some embodiments, the system may also include a second medical device.
[0081] In some embodiments, the system may further include a second imaging device comprising at least one imaging device. The second imaging device may include one, two, or more imaging devices selected from the group consisting of: ultrasound imaging devices; fluorescence microscopes and / or other X-ray imaging devices; magnetic resonance imaging (MRI) devices; CT scanners; optical coherence tomography (OCT) imaging devices; transesophageal echo imaging devices; transrectal imaging devices; catheter-based imaging devices; cystoscopes; photoacoustic imaging devices; impedance-based imaging devices; and combinations thereof. The system may be configured to generate a first set of one or more images using an ultrasound device and a second set of one or more images using the second imaging device, and the system may also be configured to compare and / or combine the first set of images with the second set of images.
[0082] In some embodiments, the system may further include an accessory device comprising at least one accessory device. The accessory device may include a positioning device configured to establish one or more reference points for use by the ultrasound equipment to create images, deliver therapeutic energy (e.g., ablation energy, stimulation energy, and / or other therapeutic energy), or both. The accessory device may include a balloon catheter, and the balloon catheter may be configured to dilate the urethral passage.
[0083] The techniques described herein, their features, and their accompanying advantages will be best understood and appreciated by reading the following detailed description in conjunction with the accompanying drawings (in which exemplary embodiments are described by way of example).
[0084] By incorporating references All publications, patents, and patent applications mentioned in this specification are incorporated herein by reference, as if each individual publication, patent, or patent application were specifically and individually indicated as incorporated by reference. The contents of all publications, patents, and patent applications mentioned in this specification are incorporated herein by reference in their entirety for all purposes. It should be clearly understood that if prior art publications are referenced herein, such reference does not constitute an acknowledgment that such publications constitute part of the general knowledge of the art in any country. Attached Figure Description
[0085] Figure 1 A block diagram of one embodiment of a system for performing medical procedures on a patient using ultrasound energy, conceived according to the present invention, is shown.
[0086] Figure 1AA block diagram of another embodiment of a system for performing medical procedures on a patient using ultrasound energy, conceived according to the present invention, is shown.
[0087] Figure 2 A schematic diagram of a system comprising an ultrasonic device and a robot manipulation assembly, according to a concept conceived in this invention, is shown.
[0088] Figure 3 A schematic diagram of an ultrasonic array conceived according to the present invention is shown.
[0089] Figure 4 A cross-sectional schematic diagram of a CMUT unit conceived according to the present invention is shown.
[0090] Figures 5A to 5C Cross-sectional views of a CMUT element comprising multiple CMUT units, as conceived according to the present invention, and a graph showing the relationship between output pressure and frequency are shown. Detailed Implementation
[0091] Reference will now be made in detail to current embodiments of the present technology, examples of which are illustrated in the accompanying drawings. Similar reference numerals may be used to refer to similar components. However, the description is not intended to limit this disclosure to the particular embodiments and should be construed as including various modifications, equivalents, and / or alternatives to the embodiments described herein.
[0092] It should be understood that the terms “comprising” (and any form of “comprising”, such as “including” and “containing”), “having” (and any form of “having”, such as “having” and “containing”), “including” (and any form of “including”, such as “including” and “comprising”), or “containing” (and any form of “containing”, such as “containing” and “including”) as used herein specify the presence of the said feature, integer, step, operation, element, and / or component, but do not exclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and / or groups thereof.
[0093] It should also be understood that although the terms first, second, third, etc., may be used herein to describe various limitations, elements, components, regions, layers, and / or parts, these limitations, elements, components, regions, layers, and / or parts should not be limited by these terms. These terms are used only to distinguish one limitation, element, component, region, layer, or part from another limitation, element, component, region, layer, or part. Therefore, the first limitation, element, component, region, layer, or part discussed below may be referred to as the second limitation, element, component, region, layer, or part without departing from the teachings of this application.
[0094] It should also be understood that when an element (also referred to herein as a “component”) is described as being “on” another element, “attached” to another element, “connected” to another element, or “coupled” to another element, it can be directly on or above the other element, or connected to or coupled to the other element, or there may be one or more intermediate elements. Conversely, when an element is described as being “directly on” another element, “directly attached” to another element, “directly connected” to another element, or “directly coupled” to another element, there are no intermediate elements. Other terms used to describe relationships between elements should be interpreted in a similar manner (e.g., “between” vs. “directly between,” “adjacent” vs. “directly adjacent,” etc.).
[0095] As used herein, the terms “operably attached,” “operably connected,” “operably coupled,” and similar terms related to component attachment shall refer to the attachment of two or more components that results in one, two, or more of the following: electrical attachment; fluid attachment; magnetic attachment; mechanical attachment; optical attachment; acoustic attachment; and / or other operably attached arrangements. Operable attachment of two or more components may facilitate the transmission of the following between the two or more components: power; signal; electrical energy; fluid or other flowable material; magnetism; mechanical linkage; light; sound such as ultrasound; and / or other materials and / or components.
[0096] It should also be understood that when the first element is referred to as “in” the “second element”, “on” the “second element” and / or “within” the “second element”, the first element can be located as: within the interior space of the second element, within a portion of the second element (e.g., within the wall of the second element); located on the outer and / or inner surface of the second element; and one or more combinations thereof.
[0097] As used herein, the term "nearby" when used to describe the proximity of a first component or location to a second component or location should be understood to include one or more locations close to the second component or location, as well as locations located in, above, and / or within the second component or location. For example, a component located near an anatomical site (e.g., a blood or other fluid delivery site) should include components located near the anatomical site, as well as components located in, above, and / or within the anatomical site.
[0098] Spatial relative terms, such as “below,” “under,” “down,” “above,” “above,” “below,” etc., may be used to describe the relationship of one element and / or feature to another(s) elements and / or features, as shown in the figures. It should also be understood that spatial relative terms are intended to cover orientations of the device other than those shown in the figures during use and / or operation. For example, if the device in the figures is flipped, an element described as “below” and / or “under” other elements or features will be oriented as “above” other elements or features. The device may be oriented in other ways (e.g., rotated 90 degrees or in other orientations), and the spatial relative descriptors used herein should be interpreted accordingly.
[0099] As used herein, the terms “reduce,” “lower,” “reduction,” etc., should be understood to include reductions in quantity, including reductions to zero. Reducing the likelihood of occurrence should include preventing occurrence. Accordingly, the terms “prevent,” “avoid,” and “avoid” should respectively include actions that “reduce,” “lower,” and “reduction.”
[0100] As used herein, the term “and / or” should be understood to specifically disclose each of two specified features or components, with or without the other. For example, “A and / or B” should be understood to specifically disclose each of the following: (i) A, (ii) B, and (iii) A and B, as if each were listed separately herein.
[0101] As used herein, the term "one or more" can mean one, two, three, four, five, six, seven, eight, nine, ten or more, up to any number.
[0102] The terms “and combinations thereof” and “and combinations thereof” may be used in this document after listing items to be included individually or collectively. For example, a component, process or other item selected from the group consisting of A, B, C, and combinations thereof should include one or more components, which include: one, two, three or more items of A; one, two, three or more items of B; and / or one, two, three or more items of C.
[0103] In this specification, unless otherwise expressly stated, “and” can mean “or”, and “or” can mean “and”. For example, if a feature is described as having A, B, or C, then the feature can have A, B, and C, or any combination of A, B, and C. Similarly, if a feature is described as having A, B, and C, then the feature can have only one or both of A, B, or C.
[0104] As used herein, when a quantifiable parameter is described as having a value "between" a first value X and a second value Y, it should include cases where the parameter has the following values: at least X, not exceeding Y, and / or at least X and not exceeding Y. For example, a length between 1 and 10 should include a length of at least 1 (including values greater than 10), a length of less than 10 (including values less than 1), and / or a value greater than 1 and less than 10.
[0105] The expression “configured (or set) to” as used in this disclosure may be used interchangeably with expressions such as “suitable for,” “capable,” “designed for,” “adapted to,” “made of,” and “capable”, as appropriate. The expression “configured (or set) to” does not imply that it is “specifically designed for” hardware only. Alternatively, in some cases, a device described as “configured to” may mean that the device is “capable” of operating with another device or component.
[0106] As used herein, the terms “about” or “approximately” should refer to ±20% of the stated value.
[0107] As used herein, the term "threshold" refers to a maximum level, minimum level, and / or range of values associated with a desired or undesirable state. In some embodiments, system parameters are maintained above a minimum threshold, below a maximum threshold, within a threshold range, and / or outside a threshold range, for example, to induce a desired effect (e.g., effective treatment) and / or to prevent or otherwise reduce (hereinafter "prevent") undesirable events (e.g., device and / or clinical adverse events). In some embodiments, system parameters are maintained above a first threshold (e.g., above a first temperature threshold to induce a desired therapeutic effect on tissue) and below a second threshold (e.g., below a second temperature threshold to prevent undesirable tissue damage). In some embodiments, thresholds are determined to include safety margins, such as to account for patient, user, and / or operator variability, system variability, tolerances, etc. As used herein, "exceeding a threshold" refers to a parameter being above a maximum threshold, below a minimum threshold, within a threshold range, and / or outside a threshold range.
[0108] As described herein, “chamber pressure” refers to the pressure of the environment surrounding the systems and devices of the present invention. Positive pressure includes pressures above chamber pressure or simply pressures greater than another pressure, such as a positive pressure differential across a fluid path component (e.g., a valve). Negative pressure includes pressures below chamber pressure or pressures less than another pressure, such as a negative pressure differential across a fluid component path (e.g., a valve). Negative pressure can include a vacuum, but does not imply pressures below a vacuum. As used herein, the term “vacuum” can be used to refer to a full vacuum or a partial vacuum, or any negative pressure described herein.
[0109] As used herein, the term “diameter” for describing non-circular geometries should be understood as the diameter of an imaginary circle that approximates the geometry being described. For example, when describing a cross-section (e.g., the cross-section of a component), the term “diameter” should be understood as representing the diameter of an imaginary circle having the same cross-sectional area as the cross-section of the component being described.
[0110] As used in this article, the terms “major axis” and “minor axis” for a component refer to the length and diameter, respectively, of the smallest imaginary cylinder that can completely enclose the component.
[0111] As used herein, the term "functional element" should be understood to include one or more elements configured and arranged to perform a function. A functional element may include sensors and / or transducers. In some embodiments, a functional element is configured to deliver energy. In some embodiments, a functional element is configured to treat tissue (e.g., a functional element configured as a therapeutic element). Alternatively or additionally, a functional element (e.g., a functional element including sensors) may be configured to record one or more parameters, such as patient physiological parameters; patient anatomical parameters (e.g., tissue geometry parameters); patient environmental parameters; and / or system parameters. In some embodiments, sensors or other functional elements are configured to perform diagnostic functions (e.g., collecting data for performing a diagnosis). In some embodiments, a functional element is configured to perform therapeutic functions (e.g., delivering therapeutic energy and / or therapeutic agents). In some embodiments, a functional element includes one or more elements configured and arranged to perform a function selected from the group consisting of: delivering energy; extracting energy (e.g., to cool components); delivering drugs or other agents; manipulating system components or patient tissue; recording or otherwise sensing parameters, such as patient physiological parameters or system parameters; and one or more combinations of these. A functional element may include fluids and / or fluid delivery systems. Functional elements may include reservoirs, such as expandable balloons or other fluid retention reservoirs. A "functional component" may include components configured and arranged to perform a function, such as diagnostic and / or therapeutic functions. A functional component may include expandable components. A functional component may include one or more functional elements.
[0112] As used herein, the term "transducer" should be understood to include any component or combination of components that receives energy or any input and produces an output. For example, a transducer may include electrodes that receive electrical energy and distribute it to tissue (e.g., based on electrode size). In some configurations, a transducer converts an electrical signal into any output, such as: light (e.g., a transducer including a light-emitting diode or a light bulb), sound (e.g., a transducer including a piezoelectric crystal configured to deliver ultrasonic energy); pressure (e.g., applied pressure or force); heat; cryogenic energy; chemical energy; mechanical energy (e.g., a transducer including a motor or solenoid); magnetic energy; and / or a different electrical signal (e.g., a signal different from the signal input to the transducer). Alternatively or additionally, a transducer may convert a physical quantity (e.g., a change in a physical quantity) into an electrical signal. A transducer may include any component that delivers energy and / or agents to tissue, such as a transducer configured to deliver one or more of the following: a transducer that delivers electrical energy to tissue (e.g., a transducer including one or more electrodes); a transducer that delivers optical energy to tissue (e.g., a transducer including a laser, a light-emitting diode, and / or an optical component such as a lens or prism); a transducer that delivers mechanical energy to tissue (e.g., a transducer including a tissue manipulation element); a transducer that delivers acoustic energy to tissue (e.g., a transducer including a piezoelectric crystal); a transducer that delivers chemical energy; a transducer that delivers electromagnetic energy; a transducer that delivers magnetic energy; and one or more combinations thereof.
[0113] As used herein, the term "fluid" can refer to a liquid, gas, gel, or any flowable material, such as a material that can be propelled through a lumen and / or opening.
[0114] As used in this article, the term "material" can refer to a single material, or a combination of two, three, four or more materials.
[0115] As used herein, the term "user interface" can include one or more interfaces, each including one or more components configured to receive input from a user (referred to herein as "user input device") and / or one or more components configured to provide output to a user (referred to herein as "user output device"). Input devices can include one, two, three, or more components selected from the group consisting of: a keyboard; a mouse; buttons; switches; levers; keypads, such as membrane keyboards; joysticks; touchscreen displays; microphones; brain-computer interfaces (e.g., thought control devices); cameras, such as cameras with eye-tracking, motion-tracking, gesture recognition, and / or other image processing capabilities, configured to recognize user input; motion capture devices, such as cameras and / or devices including one or more accelerometers; virtual input devices, such as virtual devices incorporating user input via ultrasound, image capture, and / or motion-based sensing; physiological input sensors, such as sensors configured to provide input signals based on user actions (e.g., flexion of muscles near the sensor); odor detectors, such as detectors configured to recognize pheromones or other odors produced by the user; other input components; and combinations thereof. Output devices may include one, two, three or more components selected from the group consisting of: visual output components, such as lamps and / or displays (e.g., touchscreen displays); audible output components, such as buzzers and / or speakers; tactile output components, such as vibration transducers and / or ultrasonic devices configured to generate tactile output; brain-computer interfaces; augmented reality (AR) and / or virtual reality (VR) output devices, such as glasses or head-mounted devices including opaque displays, transparent displays and / or “head-up” displays, wherein information is presented to the user in an overlay manner; odor output devices configured to generate aroma output, such as computerized odor output; other output components; and combinations thereof.
[0116] The terms “data” and “information” are used interchangeably in this document.
[0117] As used herein, the term “access” can refer to providing access to a location within a patient’s body to deliver fluids or other materials, and / or to remove fluids or other materials.
[0118] As used herein, “blood vessels of an organ” can include blood vessels that supply blood to an organ, such as arteries that supply blood to an organ; blood vessels on or within an organ, such as arteries, veins and / or capillaries within an organ; and / or blood vessels that receive blood from an organ, such as veins that receive blood from an organ.
[0119] As used herein, "treatment plan," "treatment regimen," etc., can include one or more medical procedures (e.g., diagnostic and / or therapeutic procedures) performed using systems, apparatus, and methods of the present invention. A treatment plan can include: the anatomical location of one or more tissue portions to be treated, and / or one or more anatomical locations of one or more tissue portions to be avoided; the setup of energy delivery (e.g., ultrasound delivery) to be used in diagnostic procedures (e.g., imaging procedures or other diagnostic procedures); the setup of energy delivery (e.g., ultrasound delivery) to be used in therapeutic procedures (e.g., ablation procedures, stimulation procedures, and / or other therapeutic procedures); the identity of one or more clinicians performing the medical procedures; and combinations thereof.
[0120] It should be understood that, for clarity, certain features of the inventive concept described in the context of different embodiments may also be provided in combination in a single embodiment. Conversely, for brevity, various features of the inventive concept described in the context of a single embodiment may also be provided separately or in any suitable sub-combination. For example, it should be understood that all features set forth in any claim (whether an independent claim or a dependent claim) may be combined in any given manner.
[0121] It should be understood that at least some of the figures and descriptions in this invention have been simplified to focus on elements relevant to a clear understanding of the inventive concept, while other elements that those skilled in the art would understand may also form part of the inventive concept have been omitted for clarity. However, since these elements are well known in the art and since they do not necessarily contribute to a better understanding of the inventive concept, a description of these elements is not provided herein.
[0122] The terminology defined in this disclosure is used only to describe specific embodiments of the disclosure and is not intended to limit the scope of the disclosure. Terms provided in the singular are intended to include the plural forms unless the context clearly indicates otherwise. All terms used herein (including technical and scientific terms) have the same meaning as commonly understood by one of ordinary skill in the art, unless otherwise defined herein. Terms defined in commonly used dictionaries should be interpreted as having the same or similar meaning as in the context of the related art and should not be interpreted as having an idealized or exaggerated meaning unless expressly so defined herein. In some cases, the terms defined in this disclosure should not be construed as excluding embodiments of the disclosure.
[0123] This document provides systems, apparatus, and methods for performing medical procedures (also referred to herein as “clinical procedures”) on patients, such as diagnostic procedures, therapeutic procedures (also referred to herein as “treatment procedures”), and / or other medical procedures. The system includes an ultrasound device comprising an ultrasound array containing one or more ultrasound transducers. The ultrasound array is configured to emit ultrasound waves toward target tissues of the patient.
[0124] Now for reference Figure 1 A system for performing medical procedures on a patient is illustrated. System 10 can be configured to perform medical procedures on a patient, including diagnostic procedures, therapeutic procedures, or both. The patient may include a human and / or other mammalian patient (referred to herein as a “patient”). System 10 includes one, two, or more ultrasound devices (ultrasound device 100 shown). As used herein, the terms “user,” “operator,” and / or “clinician” for system 10 may refer to a physician, nurse, clinician, and / or other healthcare professional who uses ultrasound device 100 and / or other components of system 10. Figure 1 System 10, ultrasonic device 100 and / or other components of system 10 may have the same characteristics as referenced. Figure 1A Similar construction and arrangement to similar components described elsewhere in this document.
[0125] Ultrasonic device 100 may include one, two, or more devices configured to deliver and / or receive ultrasonic energy (also simply referred to as "ultrasound"). Each ultrasonic device 100 includes one, two, or more ultrasonic arrays (ultrasonic array 150 shown), and each array 150 may include one or more ultrasonic transducers (ultrasonic transducer 155 shown, also referred to as UST 155). Each UST 155 may be configured to deliver ultrasound, receive ultrasound, or both. Each UST 155 may include a piezoelectric-based ultrasonic transducer or a capacitive micromechanical ultrasonic transducer (CMUT). In some embodiments, UST 155 may include the CMUT element 1551 described herein.
[0126] System 10 may include one, two, or more consoles and / or other modular components (console 200 shown). Console 200 may be configured to be operatively connected to ultrasound device 100 and / or another component of system 10, for example when the attachment includes electrical attachment (e.g., transmitting power, data, and / or other signals), fluid attachment (e.g., to transmit cooling fluid, hydraulic fluid, pneumatic fluid, and / or other fluids), optical attachment (e.g., to transmit laser and / or other light), mechanical attachment (e.g., to operate mechanical linkages), acoustic attachment (e.g., to transmit sound), and / or other attachments. Console 200 may be configured to be operatively connected to ultrasound device 100, for example, to transmit power and / or signals to device 100, and / or to receive signals from device 100. Console 200 may provide a user interface (as described herein) for user input of commands and / or other information from system 10, and / or for outputting information from system 10 to the user. Console 200 may have a reference... Figure 1A It has a similar construction and arrangement to the console 200 described elsewhere in this document.
[0127] System 10 may include one, two, or more cooling devices (cooling device 300 shown) configured to reduce the temperature (“cooling”) of a portion of device 100 and / or another component of system 10. Cooling device 300 may be operatively attached (e.g., fluid-attached) to at least ultrasound device 100, for example, when cooling fluid is supplied to cooling module 160 of device 100. For example, cooling module 160 may include one or more fluid paths (e.g., tubes, lumens, etc.) fluid-attached to cooling device 300. Cooling fluid used by cooling device 300 may include fluids selected from the group consisting of: water; silicone oil; fluorinated liquids; propylene glycol; ethylene glycol; mineral oil; liquid metal alloys; and combinations thereof. These fluid paths may be positioned and arranged near ultrasound array 150 and / or other components of device 100 to be cooled, and / or the fluid paths may be positioned to cool tissue near device 100. Cooling device 300 may have a reference... Figure 1A It has a similar construction and arrangement to the cooling device 300 described elsewhere in this document.
[0128] System 10 may include one, two, or more additional medical devices (the second medical device 400 shown), which can be used to perform diagnostic procedures, treatment procedures, and / or other medical procedures. The second medical device 400 may have the same features as the referenced... Figure 1A It has a similar construction and arrangement to the second medical device 400 described elsewhere in this document.
[0129] System 10 may include one, two, or more modules (processing unit 50 shown) configured to perform functions. The ultrasound device 100, console 200, cooling device 300, second medical device 400, and / or another component of system 10 may include all or part of the processing unit 50. Processing unit 50 may have the same characteristics as referenced... Figure 1A It has a similar construction and arrangement to the processing unit 50 described elsewhere in this document.
[0130] System 10 may include one, two, or more modules configured to provide a user interface (user interface 60 shown). The ultrasound device 100, console 200, cooling device 300, second medical device 400, and / or another component of system 10 may include all or part of the user interface 60. User interface 60 may have a similar design to the referenced... Figure 1A It has a similar construction and arrangement to the user interface 60 described elsewhere in this document.
[0131] System 10 may include one, two, or more elements, components, and / or other accessories (functional elements 99 shown) configured to perform functions. The ultrasound device 100, console 200, cooling device 300, second medical device 400, and / or another component of system 10 may include all or part of one or more functional elements 99. Functional elements 99 may have the same characteristics as referenced... Figure 1A It has a similar construction and arrangement to the functional element 99 described elsewhere in this document.
[0132] In some embodiments, system 10 is configured to perform an imaging procedure, for example, in the following scenario: one or more UST 155s deliver ultrasound to tissue, and one or more UST 155s (e.g., similar and / or dissimilar UST 155s) receive reflections of the delivered ultrasound, such that system 10 can generate one or more images of the tissue (e.g., target tissue) based on the timing and / or other parameters of the delivered and received ultrasound.
[0133] In alternative and / or additional embodiments, system 10 is configured to perform a “treatment procedure,” such as a treatment procedure that includes delivering ultrasound energy. System 10 may be configured to perform a treatment procedure that includes tissue treatment procedures, such as tissue ablation, tissue stimulation, and / or other tissue treatment procedures that include (e.g., delivering ultrasound energy to tissue). In these embodiments, ultrasound may be delivered to tissue by each UST 155, such as ultrasound delivered to a “target tissue” to be ablated, stimulated, and / or otherwise treated. Alternatively or additionally, the treatment procedure may include procedures in which an implant and / or agent placed in the patient’s body receives ultrasound energy from ultrasound device 100, such as delivering ultrasound energy to activate, power, and / or otherwise modify the implant and / or agent. In some embodiments, system 10 is configured to deliver ultrasound energy to activate the drug and / or other agent; and / or enhance the efficacy of the drug and / or other agent.
[0134] In some embodiments, system 10 is configured to perform a “combined imaging and treatment procedure” that includes performing one or more imaging procedures and one or more tissue ablation, tissue stimulation, and / or other tissue treatment procedures. In these embodiments, system 10 may be configured to simultaneously generate image data (e.g., creating images of tissue, agents, and / or implants within a patient) and deliver treatments (e.g., treatments including ablation, stimulation, and / or other modification of tissue, and / or modification of implants and / or agents). Alternatively or additionally, system 10 may be configured to sequentially (e.g., in a repetitive manner) generate image data (e.g., creating images of tissue, agents, and / or implants within a patient) and deliver treatments (e.g., treatments including ablation, stimulation, and / or other modification of tissue, and / or modification of implants and / or agents). In the combined imaging and treatment procedure, the energy delivery and / or other parameters of the treatment procedure (e.g., a tissue treatment procedure) may be determined based on image data collected concurrently with and / or prior to the treatment execution (e.g., automatically determined by system 10).
[0135] In some embodiments, system 10 is configured to perform: imaging of a patient's prostate, such as performing diagnostic analysis for benign prostatic hyperplasia (BPH) and / or other undesirable prostate conditions; ablation and / or other treatments of the prostate, such as performing ablation of prostate cancer tissue and / or BPH-associated tissue; or both. In some embodiments, system 10 is configured to perform a biopsy (e.g., tissue biopsy), for example when system 10 is configured to image the tissue to be biopsied prior to the biopsy.
[0136] In some embodiments, system 10 is configured to perform: imaging (e.g., for performing diagnostic analysis); treatment (e.g., ablation, stimulation, and / or other tissue treatment); or both, such as when one or both procedures are performed at an anatomical location selected from the group consisting of: the prostate (e.g., for treating BPH); the uterus (e.g., for treating endometriosis); the nasal passages and / or tongue (e.g., for treating sleep apnea); organs such as the bladder, bones, brain, heart, intestines, kidneys, liver, lungs, skin, and / or stomach; and combinations thereof.
[0137] In some embodiments, system 10 is configured to perform: imaging (e.g., for performing diagnostic analysis); treatment (e.g., ablation, stimulation, or other tissue treatment); or both, such as when one or both procedures are performed to diagnose and / or treat tissue types selected from the group consisting of: BPH tissue; tumor tissue; tissue associated with arrhythmia; tissue associated with sleep apnea and / or airway obstruction; abnormal and / or other undesirable tissue; and combinations thereof.
[0138] In some embodiments, system 10 is configured to perform diagnostic procedures to prevent or at least reduce (referred to herein as "reduce", "prevent", or "avoid") damage and / or other undesirable effects on non-target tissues. For example, in prostate tissue treatment, non-target tissues may include urethral wall tissue, seminal vesicle tissue, and / or ejaculatory duct tissue. In tumor tissue treatment, non-target tissues may include non-tumor tissues (e.g., healthy tissues). In some embodiments, tissues immediately adjacent to the target tissue include "safety margin tissues," and tissues outside the safety margin tissues include non-target tissues. In these embodiments, safety margin tissues may include tissues that are not particularly desired to be treated (e.g., ablated) but are not necessarily to be avoided.
[0139] In some embodiments, system 10 is configured to perform both diagnostic procedures (e.g., procedures that generate one or more images of tissues or other materials on and / or in the body of a patient) and therapeutic procedures (e.g., procedures in which target tissue is ablated, stimulated, and / or otherwise treated). In these embodiments, diagnostic procedures (e.g., imaging) and therapeutic procedures may be performed simultaneously, sequentially, or simultaneously and sequentially. In some embodiments, imaging and tissue treatment (e.g., ablation, stimulation, or both) are performed in an alternating manner, such as when tissue treatment (e.g., adjusting one or more ultrasound delivery and / or other treatment parameters) is adjusted based on analysis of one or more images (also referred to herein as “image data”). Adjustment of treatment parameters may be performed by system 10 (e.g., by algorithms of system 10 as described herein), by a clinician (e.g., based on information provided by system 10), or by a combination of system 10 and a clinician (e.g., when a clinician needs to confirm the acceptability of parameters “recommended” by system 10 or parameter changes).
[0140] In some embodiments, the system 10 is configured to perform diagnostic and / or therapeutic procedures, including: delivering ultrasound energy to activate drugs and / or other agents; and / or enhancing the efficacy of drugs and / or other agents.
[0141] In some embodiments, the system 10 is configured to perform medical procedures, including: delivering ultrasound energy to an implant and / or a drug, for example, to power the implant and / or the drug and / or otherwise modify the implant and / or the drug.
[0142] In some embodiments, system 10 and / or one or more components thereof have a similar construction and arrangement to the systems and components described in the following co-pending applications filed by the applicant: U.S. Patent Application Serial No. 18 / 640,305 (USD-001-US-CON2), filed April 19, 2024, entitled "Medical Device with CMUT Array and SolidState Cooling, and Associated Methods and Systems"; U.S. Patent Application Serial No. 18 / 039,978 (USD-003-US), filed June 2, 2023, entitled "Tissue Interface System"; U.S. Patent Application Serial No. 18 / 564,181 (USD-004-US), filed November 27, 2023, entitled "Tissue Treatment System"; and U.S. Patent Application Serial No. 18 / 564,181 (USD-004-US), filed May 30, 2023, entitled "Capacitive Micromechanical Ultrasonic Transducer". The contents of the U.S. patent application serial number 18 / 714,768 (USD-008-US) for “Micromachined Ultrasonic Transducer”; and / or the international PCT patent application serial number PCT / US2024 / 018763 (USD-010-PCT) filed on March 7, 2024, are incorporated herein by reference in their entirety for all purposes.
[0143] For further reference Figure 1A This illustrates another embodiment of a system for performing medical procedures conceived according to the present invention. Figure 1A System 10 can have the same Figure 1 System 10 and / or similar constructions and arrangements as described elsewhere herein. For example, Figure 1A System 10 may include an ultrasound device 100, which includes an ultrasound array 150 and an ultrasound transducer 155 (each shown in the figure), as well as a processing unit 50, a user interface 60, functional elements 99, a console 200, a cooling device 300, and / or a second medical device 400 (also shown in the figure). In some embodiments, system 10 may also include a robot manipulator assembly 500, a second imaging device 600, and / or an accessory device 700, each as shown and described herein.
[0144] Processing unit 50 may include one or more modules, each of which may be configured to perform, control, and / or monitor one or more functions of system 10 (e.g., as described herein). One or more devices or other components of system 10 may include all or part of processing unit 50, for example, when all or part of processing unit 50 is integrated into: ultrasound device 100, console 200, cooling device 300, second medical device 400, robot manipulator assembly 500, second imaging device 600, accessory device 700, and / or another component of system 10. For example, processing unit 50 may be configured to perform and / or facilitate one or more processes, data collection, data analysis, data transmission, signal processing functions, drug delivery, access element positioning, flow monitoring, monitoring of one or more patient parameters, and / or other functions of system 10 (referred to herein as "functions of system 10", "system 10 functions", or simply "system functions"). Processing unit 50 may include one or more electronic components, electronic assemblies, and / or other electronic accessories, such as components selected from the group consisting of: microprocessors; microcontrollers; state machines; memory storage components; analog-to-digital converters; rectifier circuits; filters and other signal conditioners; sensor interface circuits; transducer interface circuits; and one, two, or more combinations of these. For example, processing unit 50 may include at least one processor and at least one memory storage component, such as processor 51 and memory 52 shown. Memory 52 may be coupled to processor 51, and memory 52 may store one or more sets of computer instructions (instructions 53 shown). Instructions 53 may include instructions used by processor 51 to execute one or more algorithms of system 10. For example, system 10 may include one or more algorithms (algorithm 55 shown) executed by processor 51. Additionally or alternatively, instructions 53 may include instructions for running one or more applications of system 10 (e.g., application 56 shown). Processing unit 50 may be configured to "run" application 56, such that application 56 can initiate, modify, stop, and / or otherwise control the execution of various functions of ultrasound device 100 and / or another component of system 10. In some embodiments, application 56 is configured to receive input from a user of system 10, such as through a user interface (e.g., user interface 60 as described herein). In some embodiments, algorithm 55 may include one or more machine learning, neural network, and / or other artificial intelligence algorithms (referred to herein as "AI algorithms"). All or part of processing unit 50 may be integrated into one, two, or more of the various components of system 10, such as ultrasound device 100, console 200, server (e.g., server 80 as described herein), and / or other components of system 10. The execution of the functions of system 10 is performed by processing unit 50 as described herein.Alternatively or additionally, the execution of the functions of system 10 may be described interchangeably herein as being performed by algorithm 55 and / or system 10. For example, “algorithm 55 is configured to perform actions, routines and / or other functions” can be interpreted as processing unit 50 and / or system 10 being configured to perform such actions, routines and / or other functions, and vice versa.
[0145] As described herein, processing unit 50 (e.g., processing unit 105 of ultrasound device 100, processing unit 205 of console 205, and / or processing unit of another component of system 10) may be configured to execute one or more algorithms (algorithms 55). Each algorithm 55 may include an artificial intelligence algorithm or other algorithms. In some embodiments, system 10 is configured to generate a volumetric multidimensional image of tissue (e.g., tissue as described herein), and algorithm 55 includes an artificial intelligence algorithm or other algorithm configured to: identify tissue areas to avoid treatment; and / or suggest tissue areas to be treated.
[0146] Algorithm 55 may include artificial intelligence algorithms or other algorithms configured to evaluate image data to maintain a focal spot for delivering therapeutic energy (e.g., ablation energy, stimulation energy, and / or other therapeutic energy). Algorithm 55 may be configured to modify the delay of the signal delivered to the ultrasound transducer to maintain the focal spot.
[0147] Algorithm 55 may include artificial intelligence algorithms or other algorithms configured to identify one or more treatment modalities (e.g., ablation modalities) that have other undesirable effects of reducing edema or delivering therapeutic energy (e.g., ablation energy) to the target tissue.
[0148] Algorithm 55 may include artificial intelligence algorithms or other algorithms configured to perform self-diagnostics on system 10. For example, algorithm 55 may be configured to analyze image data (e.g., real-time or other image data collected by ultrasound device 100) during expected movement of device 100, robot manipulator assembly 500, and / or other system 10 components to detect jamming and / or other unwanted movement (e.g., lack of movement) of system 10 components (e.g., system 10 enters an alarm state when unwanted movement is detected). Alternatively or additionally, algorithm 55 may be configured to analyze data provided by system 10 sensors (e.g., functional elements including force sensors, accelerometers, position encoders, current sensors configured to monitor current of motors or other moving elements, and / or other sensors) and detect unwanted movement (e.g., lack of movement) based on the analysis of the sensor data.
[0149] Algorithm 55 may include artificial intelligence algorithms or other algorithms configured to promote image intensity uniformity, for example when algorithm 55 is configured to analyze and attenuate thermal noise.
[0150] Algorithm 55 may include artificial intelligence algorithms or other algorithms configured to remove static ultrasound artifacts caused by reflection of the incident ultrasound beam from the surface of the shaft assembly 130.
[0151] Algorithm 55 may include artificial intelligence algorithms or other algorithms configured to perform image processing and / or enhancement, such as to identify and / or enable the identification of important structures (e.g., implants or tissue structures) in an image for and / or by a clinician using system 10.
[0152] Algorithm 55 may include artificial intelligence algorithms or other algorithms configured to analyze acquired data (e.g., image data and / or other data) stored in memory (e.g., stored in memory 52) for example to provide treatment plans (e.g., recommendations for “as is” and / or treatment plans modified by clinicians using system 10).
[0153] User interface 60 may include one or more user interfaces configured to provide information to and / or receive information from system users (e.g., clinicians and / or other users of system 10). One or more devices or other components of system 10 may include all or part of user interface 60, for example, when all or part of user interface 60 is integrated into: ultrasound device 100, console 200, cooling device 300, second medical device 400, robotic manipulator assembly 500, second imaging device 600, accessory device 700, and / or another component of system 10. User interface 60 may include one or more user input components and / or output components as described herein. For example, user interface 60 may include a keyboard, mouse, touchscreen, and / or other human interface and / or other input components (user input device 61). In some embodiments, user interface 60 includes speakers, indicator lights, haptic transducers, and / or other human interface and / or other output components (user output device 62). In some embodiments, user output device 62 includes video output components, such as the display 63 shown. Display 63 may include a touchscreen display, for example, when user input device 61 and user output device 62 jointly include display 63. In some embodiments, processing unit 50 is configured to provide an interactive graphical user interface (GUI 65), such as a graphical user interface provided by application 56. GUI 65 may be displayed via display 63 (e.g., displayed to a user of system 10). In some embodiments, user interface 60 and / or GUI 65 include virtual reality and / or augmented reality interfaces. One or more components of system 10 may include one or more portions of user interface 60, such as ultrasound device 100, console 200, accessory device 700, and / or other components of system 10 described herein.
[0154] Communication module 70 may include one or more communication modules configured to send and / or receive data. One or more devices or other components of system 10 may include all or part of communication module 70, for example, when all or part of communication module 70 is integrated into: ultrasound device 100, console 200, cooling device 300, second medical device 400, robot manipulator assembly 500, second imaging device 600, accessory device 700, and / or another component of system 10. Communication module 70 may be configured to provide communication between two or more components of system 10 (e.g., transmission of commands, delivery information, patient information, and / or other data), for example, via wired and / or wireless communication. For example, communication module 70 may include one or more transmitters and / or receivers (transceiver 71 shown). Transceiver 71 may include a wireless transceiver, such as a Bluetooth transceiver, near field communication (NFC) transceiver, Wi-Fi transceiver, cellular transceiver, satellite-connected transceiver, and / or other short-range and / or long-range wireless transceiver. Wireless connectivity may include short-range wireless connectivity, such as NFC connectivity and / or Bluetooth Low Energy (BLE) connectivity. In some embodiments, communication module 70 is configured to transmit data via acoustic signals, such as acoustic signals outside the user's hearing range. In some embodiments, communication module 70 is configured to communicate via one or more wired and / or wireless networks (such as network 75 shown). Network 75 may include wireless networks, such as cellular networks, LANs, WANs, VPNs, the Internet, and / or other wireless networks connecting two or more devices. In some embodiments, network 75 includes wired networks and / or networks comprising both wired and wireless devices.
[0155] The communication module 70 can be configured to transmit data between at least a first component and at least a second component of the system 10, as described herein. In some embodiments, the first component of the system 10 includes an ultrasound device 100. The second component may include another component of the system 10, such as a console 200, a cooling device 300, a second medical device 400, a robot manipulator assembly 500, a second imaging device 600, and / or an accessory device 700.
[0156] The ultrasonic device 100 may include an elongated device having a handle assembly (handle 110) which can be connected to an extension shaft portion (shaft assembly 130), each as shown in the figure.
[0157] In some embodiments, the ultrasound device 100 includes a user interface 106, which includes at least a portion of the user interface 60 of the system 10. The user interface 106 of the ultrasound device 100 may be positioned on a handle 110. The user interface 106 may include an alarm element (e.g., an alarm element 49 of an alarm assembly 40 positioned in the handle 110), such as a tactile transducer configured to vibrate to alert the operator of the system 10 to warnings or other alarm conditions.
[0158] The shaft assembly 130 may include one or more flexible portions (e.g., two flexible portions surrounding a relatively rigid portion). One or more outer surfaces of the shaft assembly 130 may include one or more coatings, such as a lubricating coating. The ultrasound device 100 may include a catheter device. In some embodiments, the ultrasound device 100 may include one, two, three, or more devices selected from the group consisting of: catheter devices; surgical devices; devices configured for insertion via a laparoscopic guide; devices configured for insertion via a vascular guide; devices configured for insertion via an endoscope; devices configured for insertion via a surgical incision; and combinations thereof.
[0159] In some embodiments, the ultrasound device 100 is configured and arranged for insertion through the lumen of a second medical device 400, the second medical device 400 including devices selected from the group consisting of: a guide catheter, such as a guide catheter; a foley catheter; a sheath; a laparoscopic port; an endoscope; and combinations thereof. The ultrasound device 100 may be configured for insertion through the second medical device 400 configured for insertion through the bulbar urethra.
[0160] The ultrasound device 100 may include a distal portion configured to be inserted into and / or pass through one or more lumens, openings, and / or other body tubes (referred to herein as “body tubes”) of a patient, such as body tubes selected from the group consisting of: urethra; vaginal tube; blood vessel; catheter; airway; intestine; larynx; esophagus; oral cavity; anus; ear; nostril; and combinations thereof.
[0161] In some embodiments, the ultrasound device 100 includes at least a portion of a processing unit 50, at least a portion of a user interface 60, and / or at least a portion of a communication module 70, for example, when the ultrasound device 100 includes a processing unit 105, a user interface 106, and / or a communication module 107, as shown in the figures.
[0162] In some embodiments, the ultrasound device 100 includes one or more lumens and / or components (e.g., tubes), and the cooling module 160 shown is configured to cool one or more portions of the ultrasound array 150 and / or another portion of the ultrasound device 100. In some embodiments, the cooling module 160 is operatively connected (e.g., fluidly connected) to a cooling device 300 (e.g., when the cooling device 300 supplies cooling fluid to one or more lumens or other flow conduits of the ultrasound device 100 such that the ultrasound array 150 and / or another portion of the device 100 can be cooled by the cooling fluid). The cooling module 160 may be mechanically coupled to and / or otherwise positioned in the vicinity of the ultrasound array 150. The cooling module 160 may be configured to cool the ultrasound array 150, tissue in the vicinity of the ultrasound array 150, and / or treated tissue, or both. The cooling module 160 may include: a thermoelectric cooling module; a solid-state cooling module; a cooling element and a heat conductor (e.g., a solid or stranded heat conductor configured to absorb heat energy from the cooling element and / or array 150); and a fluid path (e.g., a fluid path configured to receive cooling fluid from the cooling device 300).
[0163] In some embodiments, the ultrasound device 100 includes one or more modules for sensing (sensor module 120 shown), which may include one or more sensors (sensor 125 shown), each as illustrated. In some embodiments, sensor 125 includes one or more thermocouples and / or other temperature sensors, such as temperature sensors for monitoring the temperature of one or more portions of the ultrasound array 150 and / or another portion of the ultrasound device 100, for example to allow closed-loop cooling of the device 100 via a cooling device 300 (e.g., when sensor module 120 provides temperature information to cooling device 300). Sensor 125 may include one, two, three or more sensors selected from the group consisting of: temperature sensors; pressure sensors; strain gauges; accelerometers; gyroscopes; inertial measurement units (IMUs); physiological sensors; GPS sensors; and combinations thereof. Sensor module 120 may be configured to record one or more parameters of a target tissue, one or more parameters of a non-target tissue, or both, such as one or more temperature parameters, pressure parameters, or other parameters. The sensor module 120 may include at least one sensor 125 configured to articulate, such as an articulated sensor configured to rotate and record data, for example, while avoiding applying force to tissue near at least one articulated sensor.
[0164] The ultrasonic device 100 includes an ultrasonic array 150, which includes one or more ultrasonic transducers (transducers 155), as described herein. For example, transducers 155 may include one or more capacitive micromechanical ultrasonic transducers (CMUTs), one or more piezoelectric transducers, or one or more of each.
[0165] The ultrasound array 150 may include multiple arrays 150, each array including one or more ultrasound transducers 155. The multiple ultrasound arrays 150 may include multiple independently activatable arrays, and the arrays 150 may be configured and arranged to ablate, stimulate, and / or otherwise treat tissue with a volume of at least 10 cc (e.g., at least 20 cc, 40 cc, 80 cc, 120 cc, and / or 150 cc). The ultrasound device 100 may be configured to guide and deliver therapeutic energy (e.g., ablation energy) to tissue via images provided by the ultrasound device 100, such as when the array 150 is positioned within the prostatic urethra. The multiple arrays 150 may be configured to independently create images of the patient (e.g., images of patient tissue and / or any implants within the patient), and the images may be used to provide: guidance information; diagnostic information; treatment assurance information; treatment monitoring information; and / or treatment planning information. Another component of the ultrasound device 100, console 200, and / or system 10 may include a set of electrical connections and multiplexers, wherein the multiplexers are configured to selectively connect electrical connections to each of a plurality of ultrasound arrays. A first ultrasound array 150a may be configured to emit ultrasound, and a second ultrasound array 150b may be configured to receive the emitted ultrasound (e.g., receive reflections of the emitted ultrasound), for example, when the received ultrasound is used to detect and / or measure the relative position between the first ultrasound array 150a and the second ultrasound array 150b. In some embodiments, the first array 150a, the second array 150b, or both are configured to both emit and receive ultrasound emitted by a particular array (e.g., receive reflections of ultrasound emitted by that particular array). The first ultrasound array 150a, the second ultrasound array 150b, or both may each include an array of at least 128 CMUT ultrasound transducers. The relative position between the first ultrasound array 150a and the second ultrasound array 150b can be used by the system 10 to determine a delay, wherein the delay is used to create an image using both the first ultrasound array 150a and the second ultrasound array 150b. Alternatively or additionally, the relative position between the first ultrasound array and the second ultrasound array can be used to determine the delay, and the delay can be used to deliver therapeutic energy (e.g., ablation energy, stimulation energy, and / or other therapeutic energy) to tissue using both the first ultrasound array 150a and the second ultrasound array 150b.
[0166] In some embodiments, one or more transducers 155 of one or more ultrasound arrays 150 may be configured to switch between an “imaging mode” and a “treatment mode,” such as switching between an imaging mode (in which imaging-grade ultrasound energy is delivered to and reflected from tissue) and a treatment mode (in which ablation, stimulation, and / or other therapeutic-grade ultrasound energy is delivered to ablate, stimulate, and / or otherwise treat tissue). The switching between imaging and treatment modes may occur within a time period not exceeding 6 seconds, 100 milliseconds, and / or 10 milliseconds. In some embodiments, the switching between imaging and treatment modes may occur within a time period not exceeding 1 millisecond (e.g., when performing elastography or other treatment monitoring during ablation, stimulation, and / or other tissue treatment). Another component of the ultrasound device 100, console 200, and / or system 10 may include a switching assembly configured to perform switching of the ultrasound transducers between imaging and treatment modes. The switching assembly may include a switch with a resistance not exceeding 3 ohms per channel and a capacitance not exceeding 50 pF per channel, or both. The switching assembly may include an imaging drive circuit, a therapeutic energy drive circuit (e.g., an ablation drive circuit, a stimulation drive circuit, and / or other therapeutic energy drive circuits), and a set of switches configured to switch between connecting one or more ultrasound transducers 155 to the imaging drive circuit and the therapeutic energy drive circuit. The set of switches may include microelectromechanical systems (MEMS) switches and / or low-resistance, low-capacitance switches. The imaging drive circuit may include a set of receiver amplifiers, wherein the receiver amplifiers may be positioned proximal to and adjacent to each switch in the set of switches. The switching assembly may also include a set of biasers, each biaser being positioned distal to each switch in the set of switches, and each biaser being configured to provide a DC bias to the associated ultrasound transducer 155. The switching assembly may include adjustable overvoltage protection circuitry. The therapeutic energy drive circuitry may include overshoot protection circuitry. The set of switches may include a corresponding set of pull-down resistors, and each resistor may include a resistance of at least 5 kOhm (e.g., at least 1 MOhm) and may be configured to dissipate unwanted voltages present at each switch. The switching assembly can be configured to operably connect and disconnect each ultrasonic transducer 155 from a bias voltage source. The switching assembly can also be configured to test for short circuits by connecting the ultrasonic transducer 155 to the bias voltage source and measuring the current delivered by the bias voltage source.
[0167] The ultrasound array 150 may include a group of two or more ultrasound transducers 155 arranged in a forward-viewing arrangement, a lateral-viewing arrangement, or both. In some embodiments, an acoustic lens (the acoustic lens 151 shown) covers all or a portion of the transducer 155. The acoustic lens 151 may be configured to provide focusing in the elevation direction of the ultrasound array 150, for example, to reduce the focal spot size in cooperation with electronic focusing in the azimuth direction. In these embodiments, the power density at the focal point is increased, for example, to achieve faster treatment (e.g., faster ablation). The material of the acoustic lens 151 may be selected to have a slower sound velocity than human tissue (or water) and / or to bulge toward the tissue. The mechanical impedance of the acoustic lens 151 material may be selected to match the impedance of tissue and / or other materials near the array 150 to provide optimized transmission of ultrasound energy into the tissue. In some embodiments, the material of the acoustic lens 151 may be selected to help dampen lateral modes propagating along the surface of the array 150, such as lateral modes that may impair the imaging and / or therapeutic performance (e.g., ablation performance and / or stimulation performance) of the ultrasound device 100.
[0168] In some embodiments, at least a portion of the ultrasonic array 150 is surrounded by a thermal insulation layer (e.g., a portion of the shaft assembly 130 including the thermal insulation layer). The thermal insulation layer may include a layer configured and arranged to prevent undesirable damage to tissues via the ultrasonic array 150 at temperatures above body temperature.
[0169] In some embodiments, the ultrasound device 100 includes a functional element 199 comprising an inflatable or otherwise expandable anchoring element (e.g., an inflatable balloon), such as an anchoring element configured to anchor the ultrasound array 150 relative to tissue (e.g., to create a reference point for 2D or 3D image creation and / or to prevent undesirable movement of the ultrasound array 150 during imaging, tissue treatment, and / or other procedures performed using the device 100). In some embodiments, the functional element 199 includes an expandable anchoring element configured to expand when positioned in a patient's bladder (e.g., to anchor a portion of the device 100 in the bladder). In some embodiments, the functional element 199 includes a removable sleeve, and the removable sleeve includes an expandable anchoring element. In these embodiments, the removable sleeve may also include a thermally insulating layer, such as a layer configured to prevent undesirable damage to tissue via the ultrasound array 150 at temperatures above body temperature.
[0170] In some embodiments, the ultrasound device 100 includes a shaft assembly 130, which includes a proximal portion, a distal portion, and a lumen (shown as lumen 135). Lumen 135 extends from the proximal portion of the shaft assembly 130 to the distal portion of the shaft assembly 130. Lumen 135 may extend from a location at or near the proximal end of the shaft assembly 130 and / or from a location of the handle 110, wherein lumen 135 may extend to a location at or near the distal end of the shaft assembly 130. In some embodiments, lumen 135 is configured to slidably receive an elongated device, such as a second medical device 400. For example, lumen 135 may be configured to slidably receive a second medical device 400 including a cystoscope and / or a photoacoustic device. In some embodiments, lumen 135 is configured to receive fluid, such as fluid configured to perform the following: achieving and / or enhancing acoustic coupling between the ultrasound array 150 and target tissue; cooling at least the ultrasound array 150; altering the flexibility of one or more portions of the shaft assembly 130; and any combination thereof.
[0171] In some embodiments, the ultrasound device 100 includes a functional element 199 that includes a vacuum port (e.g., one or more vacuum ports), such as a vacuum port fluidly attached to a vacuum source (e.g., provided by functional element 299 of the console 200), the vacuum port including one or more of the following: positioned near the ultrasound array 150 and configured to prevent movement of the ultrasound array 150 (e.g., during imaging and / or treatment); maintaining one or more portions of the ultrasound device 100 in contact with tissue; or both.
[0172] In some embodiments, the ultrasound device 100 includes a functional element 199 configured as an identification component (e.g., RFID or other identification component), for example, when the console 200 and / or another component of the system 10 are configured to receive ultrasound device 100 information and / or other information from the identification component. The information received from the identification component may include diagnostic information, calibration information, and / or manufacturing information of the ultrasound device 100. The information received from the identification component may be used by the console 200 and / or another component of the system 10 to confirm that the ultrasound device 100 is correctly indicated, correctly configured, and / or otherwise ready for use.
[0173] In some embodiments, the ultrasound device 100, the robotic manipulator assembly 500, and / or another component of the system 10 are configured to reduce the “clamping” force exerted on the ultrasound device 100 by tissue when a distal portion of the ultrasound device 100 is positioned in a patient’s body tube or other internal location (e.g., when positioned in the patient’s urethra for a sustained period of time (e.g., at least 1 second, 5 seconds, and / or 30 seconds)). In some embodiments, the clamping force occurs or increases during treatment (e.g., due to tissue swelling that may occur during treatment). In some embodiments, the ultrasound device 100 is configured to deliver one or more ultrasound pulses to reduce the clamping force. Alternatively or additionally, the ultrasound device 100, the robotic manipulator assembly 500, and / or another component of the system 10 are configured to vibrate one or more portions of the device 100, for example, to reduce the clamping force. In some embodiments, the ultrasound device 100 includes a functional element 199 comprising a vibrating element, such as a vibrating transducer configured to reduce clamping forces and / or reduce forces encountered when translating (e.g., advancing) the distal portion of the ultrasound device 100 through the urethra or other body tube. Alternatively or additionally, the ultrasound device 100 may include the functional element 199 comprising a lubricating and / or other coating configured to reduce clamping forces and / or reduce forces encountered when translating (e.g., advancing) the distal portion of the ultrasound device 100 through the urethra or other body tube. For example, the coating may include a polytetrafluoroethylene (PTFE) coating and / or other anti-friction coatings.
[0174] In some embodiments, the ultrasound device 100 is configured to deliver power at a high power density to treat (e.g., ablate) tissue, such as at least 100 W / cm². 2 The power density. For example, device 100 can be configured to deliver at least 100 W / cm² when device 100 is positioned within the patient's urethra. 2 To treat prostate tissue in patients with BPH. Device 100 can be configured to deliver at least 100 W / cm². 2 To treat tumor tissue and / or other tissues.
[0175] The console 200 may include one or more consoles configured to be operatively attached to one or more other components of the ultrasound device 100 and / or system 10. In some embodiments, the console 200 includes at least a portion of a processing unit 50, at least a portion of a user interface 60, and / or at least a portion of a communication module 70, for example, when the console 200 includes a processing unit 205, a user interface 206, and / or a communication module 207, as each is shown in the figures.
[0176] Console 200 may be configured to be operatively connected to one or more other components of system 10, such as to an ultrasound device 100 (e.g., multiple similar and / or different ultrasound devices 100). Console 200 may be operatively connected to ultrasound device 100 via a wired and / or wireless connection, such as via a connection provided between communication module 107 of ultrasound device 100 and communication module 207 of console 200. Console 200 may be configured to receive data, such as data 85, from ultrasound device 100, from user interface 206, from communication module 207, and / or from another component of system 10 (e.g., to “upload” data 85). In some embodiments, console 200 is configured to adjust one or more operating parameters of ultrasound device 100, for example, based on analysis of data 85. In some embodiments, data 85 includes data specific to and / or otherwise used to identify each ultrasound device 100 and / or other component of system 10, such as identification data selected from the group consisting of: serial number data; model data; manufacturing date data; usage data; fault data; battery status data; and combinations thereof. In some embodiments, console 200 is configured to upload data selected from the group consisting of: patient data; procedure data; access device data; clinician data; environmental data; time data; and combinations thereof. In some embodiments, functional element 299 of console 200 includes a data reader, such as a barcode reader, RFID reader, or other reader configured to read and / or otherwise receive data associated with components of system 10. Ultrasound device 100, console 200, cooling device 300, second medical device 400, and / or another component of system 10 may each include a data source, such as a barcode, RFID, or other data source configured to be read by console 200 and / or otherwise transmitted to console 200 for identification or other data (e.g., via functional element 299 including a data reader).
[0177] Console 200 may include one or more consoles, such as one or more similar and / or different consoles 200.
[0178] The console 200 may include the ultrasound module 250 shown, which may include one or more modules (e.g., electronic modules) configured to perform the following: providing drive signals to the ultrasound array 150 of the device 100; receiving ultrasound signals from the ultrasound array 150 of the device 100 (e.g., from recorded ultrasound reflections); or both.
[0179] In some embodiments, the ultrasound module 250 includes a dual-frequency signal generator. For example, the ultrasound module 250 may be configured to: generate a first drive signal at a first frequency for delivering ultrasound to tissue at a distance D1 from the ultrasound array 150; and generate a second drive signal at a second frequency for delivering ultrasound to tissue at a distance D2 from the ultrasound array 150, for example, when D2 is equal to or greater than D1 and the first frequency is higher than the second frequency. In some embodiments, D1 includes a distance of 25 mm or less, and the first frequency includes a frequency of at least 4.5 MHz and / or no more than 5.5 MHz, such as about 5.0 MHz. Additionally or alternatively, D2 may include a distance of 25 mm or greater, and the second frequency includes a frequency of less than 3.5 MHz and / or at least 2.5 MHz, such as about 3.0 MHz. In these embodiments, D1 may include a distance of at least 0.001 mm, and D2 may include a distance of no more than 50 mm.
[0180] The ultrasound module 250 may include tuning circuitry operating at one or more frequencies of at least 1 MHz and / or one or more frequencies not exceeding 10 MHz. The ultrasound module 250 may include two electronically switchable tuning circuits configured to provide operation at multiple different frequencies. The ultrasound module 250 may include relays and / or other switching components configured to switch between components of the two electronically switchable tuning circuits. One or more components of the first tuning circuit in the two electronically switchable tuning circuits may be shared by the second tuning circuit in the two electronically switchable tuning circuits. The ultrasound module 250 may be configured to operate a first group of one or more transducers 155 of the ultrasound array 150 at a first frequency and simultaneously operate a second group of one or more transducers 155 of the ultrasound array 150 at a second frequency different from the first frequency.
[0181] System 10 can be configured to deliver high-intensity focused ultrasound (HIFU) energy to tissue, such as to target tissue to be ablated and / or otherwise treated by delivering HIFU energy. In some embodiments, ultrasound device 100 is configured to deliver “dynamic HIFU” energy to tissue, wherein the focus of the HIFU energy can be dynamically adjusted by system 10. As used herein, a “HIFU bundle” includes a set of ultrasound signals transmitted from ultrasound array 150 to a focal point (e.g., forming a HIFU bundle). Furthermore, one or more HIFU bundles can be “formed” (e.g., ultrasound array 150 can form a HIFU bundle) and / or “delivered” (e.g., HIFU bundles can be delivered to target tissue) by ultrasound array 150. The terms “formed” and “delivered” HIFU bundles are used interchangeably herein. The ultrasound signals of a HIFU bundle include wavelength λ. A HIFU bundle can be formed by ultrasound array 150 comprising a one-dimensional (1D) array of transducers 155 and / or a two-dimensional (2D) array of transducers 155. Transducer 155 may include an ultrasonic transducer (e.g., a CMUT ultrasonic transducer) with a length or width dimension less than λ and / or a length or width dimension greater than half λ. For example, when ultrasonic array 150 includes a 1D array of transducers 155, transducer 155 may include a rectangular transducer comprising a first (length) dimension and a second (width) dimension. The second dimension of the rectangular transducer 155 may be less than λ and / or greater than half λ. Additionally or alternatively, when ultrasonic array 150 includes a 2D array of transducers 155, transducer 155 may include a square (or near-square) ultrasonic transducer comprising equal or near-equal (referred to herein as "equal" or "identical") first and second dimensions. Both dimensions of the square transducer 155 may be less than λ and / or greater than half λ. Examples of transducer 155 dimensions related to the wavelength of HIFU energy to be delivered are as follows. For HIFU including a 5 MHz ultrasonic signal, the wavelength λ in tissue is approximately 0.3 mm. The short dimension of transducer 155 will be less than 0.3 mm and greater than 0.15 mm, for example, 0.2 mm. As another example, for HIFU including a 3 MHz ultrasound signal, the wavelength λ in tissue is approximately 0.5 mm. The short dimension of transducer 155 will be less than 0.5 mm and greater than 0.25 mm, for example, 0.3 mm. Ultrasound array 150 can be configured to deliver the HIFU beam to a “highly focused” focal point, such as a focal point with a width not exceeding 1 mm (e.g., not exceeding 0.75 mm, 0.6 mm, 0.5 mm, 0.3 mm, 0.25 mm, 0.2 mm, or 0.15 mm). In some embodiments, the focal point is at a depth not exceeding 60 mm (e.g., not exceeding 40 mm).The ultrasound array 150 can be configured to steer the HIFU beam (e.g., adjust the focus of the HIFU beam), for example, to deliver the HIFU beam to a focus located away from the main beam axis of the array 150 (e.g., an axis extending perpendicularly from the center of the array to the array). For example, the ultrasound array 150 can be configured to steer the HIFU beam away from the main beam axis by up to 30°, such as at least 5°, 10°, 15°, 20°, 25°, and / or 30°.
[0182] The ultrasound module 250 may include one or more HIFU drive circuit components (HIFU driver 255 shown), which may include one or more transmission channels (e.g., driver channels configured to drive transducers 155 to transmit ultrasonic energy). The HIFU driver 255 may include M transmission channels, and the ultrasound array 150 may include N transducers 155. In some embodiments, M is equal to or greater than N (e.g., the HIFU driver 255 includes at least one dedicated driver for each transducer 155 of the ultrasound array 150). The HIFU driver 255 may be configured to independently control the phase, amplitude, and / or both phase and amplitude of each transmission channel. Each channel of the HIFU driver 255 may be controlled by the processing unit 50 (e.g., computer control, such as when the processing unit 50 includes a microcontroller and / or an FPGA). Each channel of the HIFU driver 255 may include a low-latency control loop, such as a control loop including minimal delay between parameter changes in the transmitted signal (e.g., manual changes initiated by an operator and / or automatic changes initiated by the processing unit 50, for example, via algorithm 55) and signal changes transmitted by the associated transducer 155. For example, a low-delay control loop may include a delay between 0 ms and 100 ms (e.g., approximately 5 ms). Processing unit 50 may be configured to change (e.g., dynamically change, such as while ultrasound array 150 is delivering ultrasound energy) the focusing parameters of the delivered HIFU beam, for example, to dynamically focus (or refocus) the HIFU beam. Focusing parameters may include depth of focus, aperture size, power output, and / or focus angle. The focus of the HIFU beam can be dynamically adjusted within the field of view of ultrasound array 150.
[0183] In some embodiments, the HIFU driver 255 includes one or more protection diodes 2551, each of which can be configured to prevent damage to one or more ultrasonic transducers 155. The one or more protection diodes 2551 may each have an adjustable voltage limit. The one or more protection diodes 2551 may be configured to provide high-voltage spike protection for one or more ultrasonic transducers 155, for example, to provide high-voltage spike protection to prevent “cascade breakdown” of one or more ultrasonic transducers. System 10 may include functional elements 99 including a feedback control system that modifies the amplitude and / or phase output of one or more ultrasonic transducers 155, for example, to maintain the amplitude and phase of the output voltage of each channel at target values (e.g., exceeding these values would result in damage to the transducers 155 and / or other components of the ultrasonic array 150, or other undesirable effects).
[0184] In some embodiments, the ultrasound array 150 may be configured to form two or more separate HIFU beams, such as two or more HIFU beams generated by overlapping groups of transducers 155 (e.g., two or more groups of transducers 155 including one or more common elements) and / or non-overlapping groups of transducers 155. Each of the two or more HIFU beams may be independently and dynamically controlled by the processing unit 50, as described herein. In some embodiments, the two or more HIFU beams may be focused to a single focal point (e.g., to “combine” the two beams), and / or a single HIFU beam may be “split,” for example, when a single HIFU beam is split into two or more beams focused on different targets.
[0185] In some embodiments, the number M of transmit channels of the HIFU driver 255 is less than the number N of transducers 155 of the ultrasound array 150 (e.g., M<N). For example, a 2D array may include 1000 or more transducers 155, while the HIFU driver 255 includes 256 or fewer transmit channels. The HIFU driver 255 may include one or more switch circuits, such as low-loss switch circuits, configured to multiplex the M transmit channels to the N transducers 155. For example, the HIFU driver 255 may include one or more MEMS switch circuits, for example MEMS switch circuits having a series resistance of less than 1 Ohm. In some embodiments, the switch circuit is configured to operatively couple two or more transducers 155 to a single transmit channel at the same time, such that the single transmit channel can drive the two or more transducers 155 simultaneously. In some embodiments, the total acoustic power deliverable by the ultrasound array 150 is defined by the power output capability of the HIFU driver 255. The HIFU driver 255 may be configured to form one or more HIFU beams that (collectively) deliver the maximum available acoustic power enabled by the HIFU driver 255, for example delivering the maximum power available for each transmit channel to each available transducer 155 to form the HIFU beams. Alternatively or additionally, the HIFU driver 255 may be configured to deliver one or more HIFU beams that (collectively) deliver less than the maximum available acoustic power enabled by the HIFU driver 255, for example delivering power less than the maximum enabled power to one or more transducers 155, and / or utilizing fewer than M transmit channels or fewer than N transducers 155 to deliver the HIFU beams.
[0186] In some embodiments, the number M of the HIFU driver 255 is greater than the number N of the transducers 155 in the ultrasound array 150 (e.g., M>N). For example, a 2D array may include 1000 or more transducers 155, and the HIFU driver 255 may include 1024, 2048 or more transmit channels. The HIFU driver 255 may include one or more switching circuits as described herein, configured to multiplex the M transmit channels to N transducers 155. In some embodiments, for a first energy delivery configuration (e.g., during the imaging step and / or during low-power HIFU energy delivery), a single transmit channel may be multiplexed to each transducer 155, and for a second energy delivery configuration (e.g., during high-power HIFU energy delivery), two or more transmit channels may be multiplexed to each of one or more transducers 155. In some embodiments, various transducers 155 are multiplexed to the same or different number of transmit channels during energy delivery. For example, transducers farther from the target location can be multiplexed to a greater number of transmit channels, for example, to deliver more energy. In some embodiments, the HIFU driver 255 includes transmit channels with different power capacities, for example, a first set of transmit channels configured to provide power to one or more transducers 155 at a first power level, and a second set of transmit channels configured to provide power to one or more transducers 155 at a second power level greater than the first power level. In some embodiments, each transducer 155 has a corresponding transmit channel in each set of transmit channels (e.g., M=2N).
[0187] The ultrasound module 250 may include one or more ultrasound imaging drive circuit components and / or signal recording components (imaging driver 256). The imaging driver 256 may include T transmit channels (e.g., driver channels configured to drive transducers 155 to emit ultrasound energy), and / or the imaging driver 256 may include R receive channels (e.g., channels configured to record reflected ultrasound signals sensed by transducers 155). In some embodiments, the T transmit channels include one or more transmit channels, and the R receive channels include one or more receive channels, for example, when T equals R (T=R), they are all less than or equal to N (the number of transducers 155 in the ultrasound array 150). For example, when N is greater than T and / or R, the imaging driver 256 may include one or more switching circuits (e.g., low-loss MEMS switches as described herein) configured to multiplex the T transmit channels and / or R receive channels to N transducers 155. In some embodiments, the HIFU driver 255 and the imaging driver 256 include one or more identical components, for example, when the transmit channel of the HIFU driver 255 is configured to transmit ultrasound energy for both HIFU energy delivery and tissue imaging (e.g., delivering HIFU energy during the HIFU treatment portion and delivering imaging energy during the imaging portion of the treatment procedure, as described herein). In some embodiments, the HIFU driver 255 includes the imaging driver 256, for example, when the ultrasound module 250 does not include separate transmit channels for delivering HIFU and imaging energy, and / or when the HIFU driver 255 also includes one or more receive channels.
[0188] In some embodiments, the ultrasound device 100 is configured to transmit and / or receive imaging ultrasound energy and simultaneously deliver one or more HIFU beams. For example, one or more transmit channels of the HIFU driver 255 may drive one or more transducers 155 to deliver HIFU energy, while one or more transmit and / or receive channels of the imaging driver 256 may simultaneously drive and / or record signals arriving at and / or from one or more transducers 155. In some embodiments, the HIFU driver 255 is configured to drive HIFU beams from a subset of N transducers 155 (e.g., from x transducers 155), and the imaging driver 256 is configured to image (e.g., transmit and receive imaging ultrasound energy) from a subset of N transducers 155 (e.g., from a subset comprising no more than Nx transducers 155). Each subset of the N transducers 155 may include a unique subset (e.g., no transducer 155 belongs to more than one subset). In some embodiments, subsets of transducers 155 include dynamic subsets, such that HIFU driver 255 can drive a HIFU beam from a first subset of x transducers (while imaging driver 256 can image from a second subset of no more than Nx transducers), and HIFU driver 255 can subsequently drive a HIFU beam from a third subset of x transducers (while imaging driver 256 can image from a fourth subset of no more than Nx transducers), wherein the first and third sets of transducers (and / or the second and fourth sets of transducers) are different (but potentially overlapping) subsets of transducers 155. For example, HIFU driver 255 and imaging driver 256 may each be configured to simultaneously multiplex corresponding transmit and receive channels to each transducer 155, for example, to interleave HIFU beam delivery and imaging from different portions of ultrasound array 150 (e.g., from different subsets of transducers 155) throughout the combined imaging and HIFU treatment process.
[0189] In some embodiments, system 10 includes one or more servers (server 80 shown), wherein each server 80 may be configured to provide data storage and / or data processing, such as data processing for providers of system 10 (e.g., manufacturers and / or distributors of system 10) and / or users of system 10. As used herein, data processing may refer to: receiving data; filtering, sorting, analyzing and / or otherwise processing data; transmitting data (e.g., transmitting data processing results); and / or storing data, such as data received from multiple consoles 200, multiple ultrasound devices 100, and / or multiple other components of system 10 located in various clinical locations. Server 80 may include one or more processing units 50. Additionally or alternatively, server 80 may include one or more data storage units for storing data collected by system 10 (data 85 shown). In some embodiments, server 80 is configured to process data from various users of system 10, such as when the provider of system 10 maintains one or more servers 80 configured to perform data processing for each user (and / or subset of users) of system 10 (e.g., each patient and / or clinician of system 10). Server 80 may include an "off-site" server (e.g., located away from the user's location in system 10), such as a server owned, maintained, and / or otherwise provided by the provider of system 10. Alternatively or additionally, server 80 may include a cloud-based server.
[0190] In some embodiments, data 85 includes data recorded during a medical procedure, such as data relating to one or more ultrasound energy delivery parameters and / or one or more patient parameters (e.g., the location of the tissue receiving the energy delivery and / or one or more patient physiological parameters present when the energy is delivered).
[0191] In some embodiments, server 80 is configured to communicate with one or more ultrasound devices 100, such as via network 75 between communication module 107 and server 80, and / or between communication module 107 and communication module 207 of console 200, wherein console 200 is configured to communicate with one or more ultrasound devices 100, and server 80 is configured to communicate with one or more consoles 200 (e.g., via network 75). In some embodiments, server 80 is configured to collect data 85, such as data 85 including usage information (e.g., ultrasound device 100 usage information).
[0192] As described herein, one or more components of system 10 may include all or part of processing unit 50, such as processing unit 50 including processor 51 and memory 52 coupled to processor 51, wherein memory 52 stores instructions 53 for processor 51 to execute algorithm 55. In some embodiments, algorithm 55 includes AI algorithm, for example when AI algorithm is trained based on usage data collected by server 80.
[0193] System 10 may include one or more components (alarm component 40 shown) configured to alert users of system 10. One or more devices or other components of system 10 may include all or part of alarm component 40, for example, when all or part of alarm component 40 is integrated into: ultrasound device 100, console 200, cooling device 300, second medical device 400, robot manipulator assembly 500, second imaging device 600, accessory device 700, and / or another component of system 10. Alarm component 40 may include one or more alarm elements (alarm element 49 shown) that provide visual, auditory, tactile, and / or other signals to the user. In some embodiments, alarm component 40 is configured to provide an alarm via alarm element 49, indicating to the user a warning or other alarm condition (e.g., an unexpected or other event or condition has occurred and / or exists). All or part of one or more alarm components 40 may be integrated into one, two, or more of the various components of system 10, such as into ultrasound device 100 and / or other components of system 10. For example, ultrasound device 100 may include at least a portion of alarm component 40. Alternatively or additionally, the console 200, cooling device 300, and / or second medical device 400 may include at least a portion of the alarm component 40.
[0194] In some embodiments, the alarm element 49 of the alarm assembly 40 includes two or more alarm elements. For example, the alarm assembly 40 may include a first alarm element 49a and a second alarm element 49b. The first and second alarm elements 49 may be configured to activate independently (e.g., independently alerting the user system 10 to different alarm conditions). In some embodiments, the alarm assembly 40 includes a first alarm element 49a, which includes a tactile alarm element (e.g., a tactile transducer), and a second alarm element 49b, which includes a non-tactile alarm element, such as an indicator light, speaker, or buzzer and / or other output device to alert the user to warnings and / or other alarm conditions.
[0195] In some embodiments, system 10 is configured to allow a user (e.g., a clinician) to set one or more alarm thresholds for a set of one or more parameters monitored by the system (e.g., one or more parameters monitored by ultrasound device 100, console 200, and / or other system 10 components). In these embodiments, alarm component 40 may be configured to alert one or more users of system 10, such as clinicians using ultrasound device 100, when the threshold of the monitored parameter is exceeded.
[0196] As described herein, one or more components of system 10 may include at least a portion of processing unit 50, such as corresponding processing units 105 and / or 205 of ultrasound device 100 and / or console 200, each including at least a portion of processing unit 50. The various processing units of system 10 may be referred to herein individually or collectively as processing unit 50. Processing unit 50, for example by executing algorithm 55 via processor 51, may be configured to detect target and / or non-target locations for imaging, treatment (e.g., ablation, stimulation, and / or other treatment), or both.
[0197] In some embodiments, system 10 is configured to distinguish between a first tissue type and a second tissue type. For example, image data collected using ultrasound device 100 can be used by processing unit 50 to distinguish tissue types. In some embodiments, processing unit 50 is configured to distinguish between healthy tissue and diseased tissue, ablated tissue and unablated tissue, and / or perform other distinctions within the tissue.
[0198] In some embodiments, one or more components of system 10 are configured to be calibrated. For example, one or more components of ultrasound device 100 may be configured to be calibrated.
[0199] In some embodiments, system 10 includes one or more pharmaceutical agents, contrast agents and / or other agents (pharmaceutical agent 30 shown), such as one or more agents that may be applied before, during and / or after the use of ultrasound device 100.
[0200] In some embodiments, system 10 includes one or more additional medical devices (the second medical device 400 shown). The second medical device 400 may include devices selected from the group consisting of: cystoscopes; photoacoustic devices; lithotripsy devices; brachytherapy devices; fluid delivery devices; stimulation devices (e.g., when ultrasound device 100 is configured to assist in the placement of stimulation devices); implantable devices (e.g., when ultrasound device 100 is configured to assist in the implantation of implantable devices); and combinations thereof.
[0201] In some embodiments, system 10 includes one or more components (shown as robot manipulator component 500) for robotically manipulating ultrasound device 100 and / or another component of system 10. Robot manipulator 500 may be configured to rotate ultrasound device 100, for example, to create 360° images of tissue (e.g., 2D or 3D images of tissue) and / or images of tissue sectors at least greater than 180°. Robot manipulator 500 may be configured to rotate, translate, and / or otherwise move ultrasound device 100 before, during, and / or after imaging, treatment (e.g., ablation and / or stimulation), and / or other procedures performed by device 100. In some embodiments, robot manipulator 500 is configured to perform a set of actions (translation and / or rotation) of ultrasound device 100 during an imaging procedure, for example, to create a set of images that can be stitched together to create a 3D image.
[0202] In some embodiments, system 10 includes one or more additional imaging devices (the second imaging device 600 shown). The second imaging device 600 may include one, two, or more imaging devices selected from the group consisting of: ultrasound imaging devices; fluorescence microscopes and / or other X-ray imaging devices; magnetic resonance imaging (MRI) devices; CT scanners; optical coherence tomography (OCT) imaging devices; transesophageal echo imaging devices; transrectal imaging devices; catheter-based imaging devices; cystoscopes; photoacoustic imaging devices; impedance-based imaging devices; and combinations thereof. In some embodiments, system 10 is configured to generate a first set of one or more images using ultrasound device 100 and to generate at least a second set of one or more images using the second imaging device 600. In these embodiments, system 10 may also be configured to compare and / or combine the first set of images with the second set of images. System 10 may be configured to generate one or more sets of images before and / or after any ablation or other therapeutic energy delivery (e.g., to perform closed-loop ablation or other treatment, and / or to evaluate the efficacy of ablation or other treatment).
[0203] In some embodiments, system 10 includes one or more accessory devices (accessory device 700 shown). Accessory device 700 may include a positioning device configured to establish one or more reference points that can be used by ultrasound device 100 to create images, deliver therapeutic energy (e.g., ablation energy, stimulation energy, and / or other therapeutic energy), or both. Accessory device 700 may include a balloon catheter, such as a balloon catheter configured to dilate urethral passages and / or other passages through which ultrasound device 100 is inserted. In some embodiments, accessory device 700 includes a first accessory device 710, a second accessory device 720, or both.
[0204] As described herein, system 10 may include one or more functional elements (functional element 99 shown). For example, ultrasound device 100 may include functional element 199, console 200 may include functional element 299, and / or another component of system 10 may include functional element 99. Functional element 99 may include: one, two or more sensors; one, two or more transducers; and / or one, two or more other functional elements and / or functional components.
[0205] In some embodiments, system 10 (e.g., via algorithm 55) is configured to perform a “system diagnostic procedure.” For example, system 10 may be configured to evaluate the functionality of one or more transducers 155 and / or other components of the ultrasonic array 150 (e.g., confirm their correct functioning). The evaluation may include an assessment of one or more reflections received from (e.g., transmitted and / or received by one or more transducers 155) a wall (e.g., an outer wall) of the shaft assembly 130. When one or more faulty transducers 155 are identified (e.g., confirmed via a system diagnostic procedure), system 10 may: enter an alarm state; disable the functionality of the ultrasonic array 150; allow the functionality of the ultrasonic array 150 while simultaneously disabling or compensating for one or more faulty transducers 155; and / or execute another alarm function and / or compensation function. System 10 may be configured to perform various system diagnostic procedures.
[0206] In some embodiments, system 10 is configured to determine an "orientation angle" of ultrasonic array 150 (e.g., the orientation angle of all or a portion of ultrasonic array 150), such as the orientation angle of ultrasonic array 150 relative to a portion of ultrasonic device 100. Ultrasonic device 100 may include a wall (e.g., the outer wall of shaft assembly 130 or other walls), and the orientation angle may be determined based on ultrasonic reflections received from that wall (e.g., transmitted and received by one or more transducers 155). System 10 may be configured to generate two-dimensional (2D) and / or three-dimensional (3D) images, and system 10 may enhance (e.g., correct, adjust, and / or otherwise enhance) the 2D or 3D images based on the determined orientation angle.
[0207] System 10 and ultrasound device 100 can be configured and arranged such that at least the distal portion of ultrasound device 100 can be inserted into a patient by an operator (e.g., a clinician), and ultrasound array 150 can be positioned at a desired distance from the target tissue when the insertion procedure is completed. System 10 can be configured to generate one or more images of the patient tissue prior to the completion of the insertion procedure, and ultrasound array 150 can be positioned at the desired distance based on one or more images (e.g., images used to guide insertion and / or stop the advancement of device 100).
[0208] System 10 and ultrasound device 100 can be configured to generate one or more multidimensional images (e.g., 2D and / or 3D images) of a tissue, and each multidimensional image may include at least a partial circumferential image of the tissue. Each partial circumferential image may represent a tissue sector of at least 180°, for example, representing an image up to 360° (e.g., greater than 350°). In some embodiments, manual movement (e.g., rotation, translation, or both) of ultrasound device 100 is performed (e.g., during image capture) to create a multidimensional image of the tissue. Manual movement may be performed by an operator (e.g., a clinician). In some embodiments, automatic or semi-automatic movement of device 100 (e.g., movement performed automatically or semi-automatically by robotic manipulator assembly 500, respectively) is performed (e.g., during image capture) to create a multidimensional image of the tissue. In some embodiments, movement (e.g., rotation, translation, or both) is performed based on movement-related signals provided by functional elements of system 10 including sensors (e.g., accelerometers, gyroscopes, etc.). In some embodiments, robotic manipulator assembly 500 is used to rotate and / or translate device 100 to create multidimensional images. In some embodiments, the combination of operator mobile device 100 and robot manipulator assembly 500 mobile device 100 is used to create one or more multidimensional images. System 10 may be configured to analyze (e.g., via algorithm 55) one or more multidimensional images, for example, to generate tissue information (e.g., information on 2D or 3D portions of tissue). System 10 may be configured (e.g., via algorithm 55) to perform diagnostic (e.g., clinical diagnosis) and / or treatment planning based on the generated one or more multidimensional images (e.g., based on analysis of one or more multidimensional images). In some embodiments, one or more multidimensional images include images of a patient's prostate (e.g., a large portion of the patient's prostate), for example, when the multidimensional image is based on ultrasound reflections received by device 100 when the ultrasound array 150 is positioned (e.g., rotated and / or translated) within the prostatic urethra. Ultrasound device 100 (e.g., at least a distal portion of device 100 configured to be inserted into a patient's body) may include one or more flexible portions (e.g., flexible segments) such that device 100 can be safely and efficiently translated through the patient's conduit (e.g., such that reduced forces are encountered when translating through the conduit (e.g., when translating within the prostatic urethra). In some embodiments, the ultrasound device 100 includes a rigid segment (e.g., a rigid segment in which the ultrasound array 150 is positioned), such that the rigid segment has a flexible segment at each end. The ultrasound device 100 may include one or more components with sufficient torsional strength (e.g., one or more components of the shaft assembly 130) to allow rotation within the patient conduit (e.g., smooth rotation), for example, to efficiently create multidimensional images.
[0209] Ultrasound device 100 may include multiple arrays, such as an ultrasound array 150 including a first array 150a and a second array 150b, as described herein. Functional element 199 may include a mechanical assembly configured to attach the first array 150a to the second array 150b. Functional element 199 including the mechanical assembly may be configured to switch between a first state and a second state, in which the first array 150a and the second array 150b are flexibly connected (e.g., to allow safe and efficient translation of device 100 within a patient conduit), and in a second state the first array 150a and the second array 150b are rigidly connected (e.g., a rigid condition where one or more portions of array 150 are at a known orientation angle relative to each other or another portion of device 100). In these embodiments, functional element 199 including the mechanical assembly may include a shape memory assembly, a mechanical linkage, or both.
[0210] System 10 can be configured to: automatically identify (e.g., via algorithm 55) one or more tissue markers; and / or allow an operator to manually identify one or more tissue markers. Marker identification can be used to: automatically locate and / or relocate the ultrasound array 150; and / or allow an operator to manually locate and / or relocate the ultrasound array 150. In some embodiments, system 10 uses one or more tissue markers to create a treatment plan (e.g., an automated treatment plan or other treatment plans created via algorithm 55 of system 10). Tissue markers may include the verumontanum (e.g., when treating the prostate). System 10 (e.g., via algorithm 55, such as an AI algorithm) can be configured to continuously and / or intermittently image tissue during treatment performed using ultrasound device 100, for example, to track treatment progress. System 10 can be configured to continuously or at least repeatedly confirm the proper positioning of device 100 during ablation, stimulation, and / or other tissue treatments, for example, by monitoring changes in the target tissue being treated. System 10 can be configured to provide a treatment plan and / or identify reference markers and / or safety zones.
[0211] As described herein, ultrasound device 100 may include a distal portion configured for insertion through the urethra, for example, when the system is configured to image bladder tissue and / or locations within the bladder. For example, system 10 may be configured to provide images and / or treatment of the bladder wall, and / or to diagnose and / or treat other locations within or near the bladder. In some embodiments, second imaging device 600 includes a transrectal ultrasound imaging device for bladder diagnostic and / or treatment procedures. Alternatively, system 10 may be configured to diagnose and / or treat a patient's bladder without using transrectal ultrasound imaging.
[0212] System 10 (e.g., using ultrasound device 100) can be configured to perform a biopsy procedure on a patient. For example, the second medical device 400 may include a biopsy collection device, and system 10 can be configured to collect biopsies via image data provided by ultrasound device 100. System 10 can be configured to perform biopsies in various configurations.
[0213] System 10 can also be configured to "optimize" (e.g., improve for subsequent manual and / or automated analysis) a set of one or more images, for example, via the use of harmonic imaging. As described herein, ultrasound device 100 may include a distal portion configured for insertion through one or more conduits in the patient (e.g., the prostatic urethra and / or one or more other body cavities). System 10 can be configured to create and optimize a set of one or more images during and / or after insertion through the body cavity.
[0214] System 10 may be configured to (e.g., via ultrasound device 100 and / or algorithm 55) determine one or more characteristics of a tissue. System 10 may be configured to determine tissue characteristics based on attenuation measurements of ultrasound delivered by ultrasound array 150. System 10 may be configured to use the determined tissue characteristics to: predict the efficacy of ablation and / or other tissue treatments using ultrasound device 100; determine one or more ultrasound delivery parameters used by device 100 to perform ablation and / or other tissue treatments; and / or calibrate one or more portions of system 10 (e.g., imaging-related portions, energy delivery-related portions, or both).
[0215] As described herein, ultrasound device 100 can be configured to deliver ultrasound to treat a patient (e.g., ablate, stimulate, and / or otherwise treat target tissue of the patient), and system 10 can be configured (e.g., via algorithm 55) to monitor the progress of treatment. System 10 can be configured to perform monitoring of treatment progress by simulating heat propagation generated by ultrasound delivery, for example, based on: ultrasound delivery parameters; parameters of ultrasound device 100; and / or parameters of tissue and other materials near ultrasound array 150 during ultrasound delivery. System 10 can be configured to simulate heat propagation based on: measuring tissue attenuation using ultrasound images generated by system 10. System 10 can be configured to measure tissue attenuation by analyzing the relationship between signal-to-noise ratio and depth. The analysis of system 10 may include analysis of data (e.g., image data) acquired before and during the delivery of therapeutic ultrasound energy. System 10 can also be configured (e.g., via algorithm 55) to provide a “confidence range” related to monitoring of treatment progress. In monitoring treatment, system 10 can be configured to consider: changes in one or more properties of the tissue or other tissue-related changes, such as one or more tissue-related properties selected from the group consisting of: absorption; perfusion; backscattering; temperature; elasticity; displacement (e.g., caused by energy delivery); intensity distribution; other tissue properties that may change during treatment; and combinations thereof. System 10 can be configured to monitor one or more parameters of ultrasound transducer 155, and system 10 can be configured to perform monitoring of treatment progress based on the monitored ultrasound transducer parameters. System 10 can be configured to collect image data, for example, when system 10 is also configured to perform monitoring of treatment progress based on the collected image data. System 10 can use local image intensity statistics techniques to assess tissue changes over time, for example, when the collected image data includes images taken before, during, and after treatment (e.g., images collected with the same field of view). The local image intensity statistical techniques used by System 10 may include extracting local image statistics, such as local image statistics including: local mean; local standard deviation; local extrema; local kurtosis; local skewness; and / or local higher-order normalized moments. The image intensity statistical techniques used by System 10 may include: principal component analysis; singular value decomposition; and / or other feature extraction and / or selection techniques. The image intensity statistical techniques used by System 10 (e.g., for assessing tissue changes over time) may be performed on one or more local regions of the image, such as including a “neighborhood” of a pixel grid, such as a 5x5, 5x11, 11x21, or 21x11 pixel grid.In some embodiments, changes in tissue properties (e.g., significant changes in tissue properties) are associated with: local mean intensity changes of at least 1 dB, 5 dB, or 10 dB; local intensity standard deviations of intensity changes of at least 0.1 dB, 0.5 dB, or 1 dB; local median intensity changes of at least 1 dB, 5 dB, or 10 dB; local minimum intensity changes of at least 1 dB, 5 dB, or 10 dB; local maximum intensity changes of at least 1 dB, 5 dB, or 10 dB; local intensity skewness changes of at least 0.1 dB, 0.5 dB, or 1 dB; and / or local intensity kurtosis changes of at least 0.1 dB, 0.5 dB, or 1 dB. In some embodiments, system 10 is configured to perform dimensionality reduction techniques (e.g., PCA, ICA, SVD) to reduce the number of metrics (e.g., from seven or more independent metrics to four or fewer optimized metric combinations). Treatment monitoring performed by system 10 may include: capturing a first set of one or more images prior to treatment; capturing a second set of one or more images after treatment; and combining and / or comparing the first set of one or more images with the second set of one or more images. System 10 may be configured to produce visual output (e.g., provided by user interface 106 or other user interface 60) in which tissue properties representing ablation, stimulation, or other treatment effects are highlighted, color-coded, segmented, and / or otherwise graphically distinguished.
[0216] As described herein, system 10 can be configured to perform various treatment procedures, including the delivery of ultrasound. In some embodiments, system 10 can also be configured to generate a “treatment log” representing the relevant treatment parameters used and / or the treatment outcomes achieved. The treatment log can include a comparison of the tissue to be treated with the tissue actually treated. System 10 can be configured to generate the treatment log (e.g., at least a portion of the treatment log) before the treatment procedure is completed. The treatment log generated by system 10 can include analysis of one or more treatment parameters, such as: pressure zone; ablated tissue volume; ablated tissue volume relative to the total volume; stimulated tissue volume; and / or stimulated tissue volume relative to the total tissue volume.
[0217] In some embodiments, and as referenced Figures 5A-5CAs described elsewhere herein, system 10 is configured to operate ultrasonic array 150 using one or more operating parameters (e.g., fractional bandwidth, operating frequency, number of elements, and size, etc.) above a minimum and / or below a maximum (e.g., within a range) to improve plate displacement uniformity (e.g., plate 1557 displacement uniformity within CMUT element 1551 described herein), extend the lifespan of array 150, prevent damage to array 150, and / or otherwise improve the performance of array 150. For example, system 10 may be configured to operate ultrasonic array 150 with a fractional bandwidth of at least 65%, not exceeding 100%, or both, and with a ratio of maximum plate displacement to median plate displacement not exceeding 150% (1.5:1). Alternatively or additionally, system 10 may be configured to operate the ultrasonic array 150 at a frequency of at least 80% and no more than 100% of the center frequency of the ultrasonic transducer 155, and at a frequency of at least 80% and no more than 160% of the center frequency of the ultrasonic transducer during energy delivery to generate image data. In some embodiments, system 10 is configured to perform harmonic imaging at a transmit frequency of about 4 MHz and a receive frequency of about 8 MHz. In some embodiments, one or more transducers 155 of array 150 each include CMUT elements 1551, each element 1551 including an X-by-Y arrangement of CMUT cells 1552, wherein X is one cell 1552 or two cells 1552, and Y is at least four cells 1552.
[0218] In some embodiments, the ultrasonic array 150 includes a CMUT 1551 as described herein, and the array 150 is configured to have specific performance characteristics (e.g., pressure output and lifespan), such as generating a surface pressure of at least 1 MPa peak-to-peak over a time period of at least 15 minutes, 20 minutes, or 30 minutes when the array 150 and the CMUT element 1551 are configured (e.g., operating at a frequency of at least 3 MHz, no more than 7 MHz, or both, and / or with a duty cycle of at least 70%, 80%, and / or 90%). In these embodiments, the ultrasonic array 150 may utilize a maximum AC+DC transmit voltage of no more than 220 V, and / or the array 150 may have a fractional bandwidth of at least 65%.
[0219] Now for reference Figure 2 The diagram shows a system comprising an ultrasonic device and a robot manipulator assembly according to the present invention. Figure 2 System 10 can have the same Figure 1 and / or Figure 1A The system 10 and / or similar constructions and arrangements described elsewhere in this document. Figure 2System 10 includes a robotic manipulator assembly 500 operatively attached to ultrasound device 100. The robotic manipulator assembly 500 can be configured to robotically translate (e.g., advance and / or retract), rotate, turn, and / or otherwise manipulate ultrasound device 100. Alternatively or additionally, the robotic manipulator assembly 500 can be configured to robotically manipulate another component of system 10.
[0220] The ultrasound device 100 may include a shaft assembly 130 extending distally from a handle 110. An ultrasound array 150 may be located in the distal portion of the shaft assembly 130, as shown. The shaft assembly 130 may include one or more elongated shafts (shafts 131). The shaft assembly 130 may include one or more channels and / or lumens therethrough, such as a guidewire lumen 132 extending from a proximal portion of the shaft 131 to a distal portion (e.g., away from the distal end) of the shaft 131. The guidewire lumen 132 may be configured and arranged to slidably receive a guidewire and / or other elongated devices. Additionally or alternatively, the shaft assembly 130 may include one or more other lumens, such as lumen 135 as described herein. The shaft assembly 130 may include one or more catheters and / or links, such as the communication path 133 shown. The communication path 133 may include one or more communication paths operatively connecting one or more components of the ultrasound device 100 to one or more components of the robot assembly 500 and / or one or more components of the console 200 (connections not shown). Communication path 133 may include one or more mechanical links, such as links configured to steer a portion of shaft assembly 130, and / or electrical conduits, such as one or more wires configured to operatively connect an assembly (e.g., ultrasonic array 150) to a controller (e.g., a controller of robot assembly 500 and / or console 200, as described herein).
[0221] The ultrasonic array 150 may include a transducer 155, which may be located in the distal portion of the shaft assembly 130, as shown. The ultrasonic array 150 may include an acoustic lens 151, which may be located near the transducer 155 and configured to focus and / or otherwise manipulate ultrasonic signals propagating toward and / or from the transducer 155. In some embodiments, the ultrasonic device 100 includes a sensor 125, such as the temperature sensor 125a shown. The temperature sensor 125a may be configured to provide a signal relating to the temperature of a portion of the shaft assembly 130, the ultrasonic array 150, and / or tissue surrounding the shaft assembly 130. The ultrasonic device 100 may include a cooling assembly 160, which may be located within the distal portion of the shaft assembly 130, for example, close to the ultrasonic array 150. The cooling assembly 160 may be configured to cool the ultrasonic array 150 and / or tissue surrounding the shaft assembly 130. In some embodiments, the cooling assembly 160 includes one or more cooling elements, such as a heat exchanger 161. Heat exchanger 161 may include passive and / or active heat exchangers, such as fluid-cooled heat exchangers and / or thermoelectric heat exchangers. Cooling assembly 160 may include one or more channels (heat pipe 162 shown) for transferring energy (e.g., heat energy) from heat exchanger 161. In some embodiments, heat pipe 162 includes one, two or more fluid conduits configured to transport circulating cooling fluid to and / or from heat exchanger 161.
[0222] In some embodiments, the handle 110 is configured to be operatively attached to the robot assembly 500, such that positioning and / or other manipulation of the ultrasonic device 100 can be performed by the robot assembly 500, as described herein. The robot assembly 500 may include a sub-assembly (steering sub-assembly 510) for manipulating the shape of the shaft assembly 130 and / or steering one or more portions of the shaft assembly 130. The steering sub-assembly 510 may be configured to actuate one or more steering lines or other links, such as a communication path 133 configured to manipulate the mechanical links of the shaft assembly 130. The robot assembly 500 may include one or more sub-assemblies for manipulating the 3D positioning of the ultrasonic device 100, such as the illustrated translation sub-assembly 520 and / or rotation sub-assembly 530. The translation sub-assembly 520 may include one or more motion elements (illustrated translation motor 525), and / or one or more encoders or sensors (illustrated translation encoder 526). The rotation sub-assembly 530 may include one or more motion elements (illustrated rotation motor 535), and / or one or more encoders or sensors (illustrated rotation encoder 536).
[0223] Now for reference Figure 3 The diagram shows a schematic of an ultrasonic array conceived according to the present invention. Figure 3 The ultrasound array 150 can have the same characteristics as the reference array. Figure 1 and / or Figure 1A The ultrasonic array 150 may have a similar construction and arrangement as described elsewhere herein. The ultrasonic array 150 may include one or more ultrasonic transducers, such as the transducers 155a and 155b shown. Each transducer 155 may include CMUT transducer elements (CMUT element 1551 shown), and each CMUT transducer element includes an array of CMUT cells (cells 1552 shown). The cells 1552 may be arranged in rows and columns, such as the four columns shown, with ten cells 1552 per column. Each CMUT element 1551 may include a... Figure 3 The number of rows and / or columns 1552 may be more or fewer, for example, as few as a single cell 1552 (e.g., a 1x1 grid of cells 1552), and / or for example, at least 2 rows, each with at least 4 cells, or for example, two rows, each with approximately 39 cells.
[0224] As shown and described herein, each CMUT element 1551 may include a plurality of units (e.g., unit 1552 of the illustrated CMUT element 1551). Each CMUT unit 1552 may include a plate (e.g., top plate 1557 described herein) which may be configured to deflect in response to an electrical signal, for example, to generate a pressure wave. In some embodiments, the ratio of the maximum plate 1557 displacement to the median plate 1557 displacement is maintained at a ratio not exceeding 150% (1.5:1). In some embodiments, the plate displacements of different units 1552 within element 1551 may be out of phase with each other. The maximum pressure that element 1551 can generate may be limited by the maximum plate displacement achievable without the plate contacting (e.g., impacting) the bottom of unit 1552. Contact between the plate and the bottom of unit 1552 may cause one or more reliability problems, such as problems due to charging and / or electrical breakdown. For example, charging is a phenomenon in which static charge is trapped in an insulating layer (e.g., insulating layer 1554, as described herein) between the top electrode and the bottom electrode (e.g., top plate 1557 and substrate 1553, as described herein, respectively). The trapped charge can generate an effective DC voltage on the cell (e.g., cell 1552, as shown), causing changes in cell behavior during operation. When the plate is not in contact with the bottom of cell 1552, the electric field is distributed between the gap (e.g., chamber 1556, as described herein) and the insulating layer. However, when the plate is in contact with the bottom of the cell, the electric field is concentrated within the insulating layer. This exacerbates the charging effect and can lead to cell breakdown. When the plate displacement of cell 1552 of element 1551 is uneven (e.g., resulting in undesirable contact between the plate and the bottom of the cell), the maximum output pressure of element 1551 may be significantly reduced because the plate of cell 1552 with a larger plate displacement is in contact with the bottom of the cell, while the average displacement on the cell of element 1551 is much smaller than the full gap height (e.g., the total physical distance from the undeflected plate to the bottom of the cell).
[0225] Array 150 can be configured to avoid one or more problems or other limitations associated with the negative effects of "mutual acoustic impedance." Mutual acoustic impedance (or "mutual resistance") describes the acoustic coupling between units (e.g., unit 1552 of element 1551) in a transducer. It can also be considered as applying pressure to one unit causing movement of another unit. During CMUT unit operation (e.g., when the unit's plate vibrates), acoustic forces are applied to the plate. This acoustic force is proportional to the plate's velocity and acoustic impedance. Acoustic impedance is the sum of two components: the unit's self-acoustic impedance, which is affected by the plate radius; and the properties of the surrounding medium. Mutual acoustic impedance depends on the distance between two or more units, the velocity of the unit plate, and the properties of the surrounding medium. Mutual acoustic impedance can vary based on the distance between unit 1552 and adjacent units. As a result, the mutual acoustic impedance between units differs between units within element 1551. This variation in acoustic impedance across units leads to differences in their dynamic responses, causing amplitude and phase variations in plate vibration and non-uniformity in plate displacement.
[0226] In some embodiments, the non-uniformity of plate displacement of CMUT element 1551 is caused by acoustic interactions between cells 1552 (e.g., by mutual impedance between cells). For example, pressure waves from the first cell 1552 may affect the plate displacement of the second cell 1552 (e.g., the cell 1552 adjacent to the first cell 1552). In some embodiments, the maximum voltage applied to CMUT element 1551 can be limited to a voltage less than that which would cause the plate with the maximum displacement to impact or otherwise contact the bottom of the associated cell 1552. This operational limitation (e.g., the limitation caused by the non-uniformity of plate displacement of CMUT element 1551) can reduce the applicable voltage applied to CMUT element 1551 to a relatively low voltage, thereby limiting the average plate displacement of CMUT element 1551 and / or limiting the output pressure of element 1551.
[0227] When operating in HIFU mode, the cell non-uniformity problem is exacerbated because quasi-continuous wave operation allows the interaction between cells (e.g., cell 1552) to fully develop and establish non-uniform displacement on at least a portion of an element (e.g., CMUT element 1551), on a group of elements, and / or on at least a portion of an array (e.g., array 150). In some embodiments, HIFU operation of the CMUT element (e.g., CMUT element 1551) is performed at a high voltage, which results in a high electric field in the insulating layer (e.g., insulating layer 1554 described herein) and increases the likelihood of failure of one or more cells 1552 relative to the overall failure likelihood of the CMUT element 1551.
[0228] Now for reference Figure 4The diagram shows a cross-sectional schematic of a CMUT unit according to the present invention. Figure 4 The CMUT unit 1552 can have the same characteristics as the reference. Figure 1 and / or Figure 1A Similar construction and arrangement to related components of System 10 described elsewhere herein. CMUT elements (e.g., CMUT element 1551 described herein) may include an array of cells 1552, for example constructed and arranged in a manner similar to... Figure 4 Unit 1552 is the unit 1552 shown and described. Unit 1552 may include multiple layers, such as multiple layers fabricated on a substrate (substrate 1553 shown) (e.g., fabricated by deposition, consumption, or other silicon manufacturing processes). Unit 1552 may include: one or more insulating layers (e.g., insulating layer 1554 shown); one or more walls surrounding a void (e.g., walls 1555 surrounding chamber 1556 shown respectively); and / or one or more top layers (e.g., top plate 1557) and / or metal layers 1558 that enclose chamber 1556, as each is shown.
[0229] In some embodiments, the thickness of the insulating layer 1554 of the CMUT cell 1552 is selected to improve its robustness to breakdown (e.g., reducing the likelihood of cell 1552 failing when an electrical signal is applied to cell 1552). The insulating layer 1554 may comprise an insulating material layer between the top and bottom electrodes of the CMUT cell (e.g., an insulating material layer between substrate 1553 and top plate 1557, as shown). The insulating layer 1554 may be composed of silicon dioxide (e.g., silicon dioxide manufactured using thermal oxidation) or may be composed of another dielectric material. In some embodiments, the insulating layer 1554 comprises silicon dioxide manufactured using other methods, such as silicon dioxide deposited using chemical vapor deposition. In some embodiments, the insulating layer 1554 is composed of other dielectric materials, such as silicon nitride. In some embodiments, the insulating layer 1554 comprises two or more layers, for example, each comprising two or more layers of different materials. In some embodiments, the insulating layer 1554 is positioned at the bottom of the cell 1552 (e.g., on the top surface of the substrate 1553, as shown) and / or at the bottom of the top plate (e.g., on the bottom surface of the top plate 1557). In some embodiments, the insulating layer 1554 comprises two layers positioned on both the top surface of the substrate 1553 and the bottom surface of the top plate 1557.
[0230] The insulating layer 1554 includes a height (e.g., the thickness of the layer), as shown in the height H1. The height H1 can be selected such that the unit 1552 will not break down under normal operating voltages, for example, even if the top plate 1557 contacts the bottom of the unit (e.g., the bottom of the chamber 1556). Even if the system is designed so that no CMUT plate contacts the bottom of the unit under normal operating conditions, unexpected events may occur that cause the plate to contact the bottom of the unit. It is advantageous if the CMUT can withstand these events to reduce the likelihood of damage, degradation, or failure during operation. The breakdown voltage of the insulating layer material can be configured (e.g., selected) to avoid breakdown. A set of measurements can be performed on multiple samples to find the distribution of relevant breakdown voltages (e.g., an experimental procedure performed in the development of the ultrasonic device 100). The insulating layer thickness can then be selected such that the electric field in the insulator is low enough to prevent breakdown with a high probability. In some embodiments, limiting the maximum electric field within the insulating layer 1554 can reduce the likelihood of adhesion by preventing current from flowing through the insulating layer 1554 when the top plate 1557 contacts the bottom of the chamber 1556.
[0231] The drive signals for the CMUT may include a combination of AC and DC voltages. In some embodiments, there exists a set of AC and DC voltage combinations that collectively result in a maximum operating voltage. The thickness of the insulating layer 1554 can be selected to withstand the maximum combination of AC and DC voltages in this set. Several limitations may exist on the maximum operating voltage of the CMUT. One or more of the maximum operating voltages can be determined by analyzing the following: the voltage that would cause the board to impact or otherwise contact the bottom of the unit; limitations of the electronic system that generates the voltage; voltage ratings of other system components; and combinations thereof.
[0232] In some embodiments, increasing the thickness of the insulating layer 1554 may degrade the performance of the cell 1552. For example, while other dimensions remain constant, increasing the thickness of the insulating layer 1554 may reduce transmit and receive sensitivity, which may increase the voltage required to generate the desired output pressure. In some embodiments, to increase transmit and receive sensitivity, the height of the chamber 1556 (e.g., the spacing between the insulating layer 1554 and the top plate 1557) may be reduced (e.g., to compensate for the increased thickness of the insulating layer 1554) so that the pull-in voltage remains unchanged. The pull-in voltage is the DC voltage at which the top plate 1557 is pulled down to the bottom of the cell (e.g., so that the top plate 1557 contacts the insulating layer 1554). This configuration may keep the operating voltage approximately the same but reduces the maximum plate displacement and thus the maximum output pressure. In some embodiments, the thickness of the insulating layer 1554 is selected to be at least as thick as reliably preventing cell 1552 from breaking down, but up to 50% larger than that required thickness, for example, about 25% larger.
[0233] In some embodiments, with all other dimensions of cell 1552 remaining constant, both transmit sensitivity and receive sensitivity decrease, and breakdown voltage increases, as the thickness of insulating layer 1554 increases. If the pull-in voltage of cell 1552 remains constant, the maximum stress of cell 1552 may decrease, and breakdown voltage may increase, as the thickness of insulating layer 1554 increases.
[0234] In some embodiments, the thickness of the insulating layer 1554 is non-uniform. For example, one or more regions of the insulating layer 1554 may be thinner than the thickness required to prevent breakdown. In some embodiments, these thinner regions do not increase the risk of breakdown, for example, as long as the top plate 1557 contacts a thicker region of the insulating layer 1554 when it contacts the bottom of the cell. Additionally or alternatively, the insulating layer 1554 may have regions thicker than the minimum thickness required to prevent breakdown, for example, when there is space available for a thicker insulating layer without obstructing the top plate 1557. The breakdown voltage of the CMUT cell (e.g., cell 1552) may vary significantly depending on whether a positive or negative voltage is applied to the top electrode relative to the bottom electrode. In some embodiments, cell 1552 may operate with a polarity associated with a higher breakdown voltage. For example, if both the top plate 1557 and the substrate 1553 are composed of p-type silicon, a positive voltage can be used to maximize the breakdown voltage.
[0235] Now for reference Figures 5A to 5C The diagram shows first and second cross-sectional views of a CMUT element comprising multiple CMUT units according to the present invention, as well as a graph showing the relationship between output pressure and frequency. Figure 5A and 5B The CMUT element 1551 can have the same characteristics as the reference. Figure 1 and / or Figure 1A Similar construction and arrangement to CMUT element 1551 described elsewhere herein. CMUT elements (such as CMUT element 1551 described herein) may include an array of cells 1552, for example constructed and arranged similarly to reference CMUT element 1551. Figure 4 Unit 1552 of the aforementioned unit 1552. Figure 5A and 5B The concepts of element displacement and phase inhomogeneity described in this paper are illustrated.
[0236] For example, Figure 5A and 5B The non-uniformity of plate movement that may occur during the firing of the CMUT unit is shown. Figure 5A and 5B It passes through the same array element 1551 (i.e., Figure 5A and Figure 5BThe diagram shows a cross-sectional view of four elements (elements 1552a-d) of the same array. This cross-section is along the orientation direction (e.g., across the width of element 1551).
[0237] Ideally, elements 1552a-d should shift with the same amplitude and phase. However, in practical applications, the amplitude and phase between elements 1552 may differ significantly, such as... Figure 5A and 5B As shown. Figure 5A The diagram illustrates a scenario where elements 1552a-d move in phase but with different amplitudes. As shown, elements 1552a and 1552d can have larger amplitudes than elements 1552b and 1552c. Figure 5B The illustration shows units 1552a-d with the same amplitude but different phases. Units 1552a and 1552d are out of phase with units 1552b and 1552c. These are examples illustrating inhomogeneities related to amplitude or phase. In some embodiments, unit 1552 may have both amplitude and phase inhomogeneities. The mode of inhomogeneity may also differ from... Figure 5A As shown in 5B. For example, in some embodiments, all four units 1552a-d may have different amplitudes and / or phases.
[0238] Figure 5C An example graph of emitter pressure versus frequency for an example CMUT element 1551 with a center frequency of 5 MHz is shown. Ideally, the pressure should decrease smoothly away from the center frequency. However, in this example, a large peak exists at 3.7 MHz due to the interaction between cells 1552. This peak would not be expected in a single-cell model. Figure 5C The frequency response shown may exhibit a significant peak (e.g., as shown in the figure) or a significant drop, depending on the cell distribution within the element.
[0239] In some embodiments, system 10 is configured to operate ultrasound array 150 such that the ratio of the displacement of the maximum plate 1557 to the displacement of the median plate 1557 does not exceed 150% (1.5:1). In these embodiments, system 10 may be configured to operate array 150 with a fractional bandwidth of at least 65%, not exceeding 100%, or both. During the delivery of therapeutic energy (e.g., ablation energy), system 10 may be configured to operate array 150 within a frequency range of 80% to 100% of the center frequency of one or more ultrasound transducers 155; and during the delivery of energy to generate image data, system 10 may be configured to operate ultrasound array 150 within a frequency range of 80% to 160% of the center frequency of one or more ultrasound transducers 155.
[0240] The CMUT design conceived in this invention can operate at frequencies above 4.2 MHz, thus avoiding the frequency range where inter-cell interactions have a strong effect. This design exemplifies the general principle that strong inter-cell interaction effects occur at frequencies below the center frequency. In some embodiments, the CMUT is configured to operate at frequencies just below (approximately 0-20% lower, depending on the design) or higher than its center frequency, particularly for applications with array 150 exhibiting high pressure and long transmit pulse trains.
[0241] For example, in an application where array 150 requires transmission operation at 5 MHz and 9 MHz, a configuration with a center frequency of 7 MHz may perform poorly due to strong cell interactions at 5 MHz. Therefore, array 150 can operate, for example, at a center frequency of 5 MHz or 5.5 MHz.
[0242] In various embodiments, the CMUT element (e.g., CMUT element 1551) may consist of a different number of cells 1552, such as an X-by-Y array of cells 1552, where both X and Y are greater than or equal to 1. The number of cells 1552 on the width (or orientation or X dimension) of each element 1551 may be selected to reduce plate displacement inhomogeneity.
[0243] In some embodiments, the width of element 1551 (e.g., the number of cells 1552 of element 1551 in the X or azimuth direction) can be selected based on the following algorithmic process. The spacing of elements 1551 (e.g., the periodicity of repetition of elements 1551 along the X direction) can be selected to eliminate grating lobes based on the ultrasonic frequency and imaging type. For example, linear array imaging requires a spacing approximately equal to the wavelength of the sound wave in the medium (i.e., the material through which ultrasonic energy propagates), and phased array imaging requires a spacing approximately equal to half that wavelength. In some embodiments, the notch is selected to be as small as possible given manufacturing constraints and the requirement for electrical isolation of adjacent elements. The cell size can be selected to fill the area of element 1551 as much as possible, allowing for some bonding regions between cells 1552 and between the outer edges of cells 1552 and the edges of element 1551. The width of the bonding regions may be limited by bonding quality and yield. In some embodiments, the width of each cell 1552 plus the width of the bonding regions can be approximately the width of element 1551 divided by an integer (e.g., 1, 2, 3, 4, etc.).
[0244] When the frequency of the drive signal for array 150 remains constant (e.g., when similar drive signals are delivered to elements 1551 and / or cells 1552 with different configurations), larger cells 1552 typically have smaller bandwidths, which can limit ultrasound imaging performance. For example, in some embodiments, ultrasound imaging requires a wide frequency bandwidth, such as at least 55%, 62%, and / or 70% of the frequency bandwidth. Larger cells 1552 can also exhibit smaller displacement inhomogeneities, which can increase HIFU performance. For example, smaller displacement inhomogeneities can provide better reliability, which can be beneficial for HIFU applications. For dual-mode HIFU and imaging operations, to optimize the performance of both HIFU and imaging operations, cells 1552 should be as large as possible while maintaining sufficient imaging bandwidth, such as at least 65% or at least 70% of the fractional bandwidth. For HIFU applications, since bandwidth is not an issue, the width of cells 1552 is limited by the element width (e.g., in some embodiments, it is possible to include elements with a single cell 1552 in the azimuth direction).
[0245] This document describes various illustrative examples of CMUT element designs. The dimensions described can be derived algorithmically to optimize the imaging and HIFU performance of the elements, as described herein. Examples of phased arrays with center frequencies of 3 MHz, 6 MHz, and 10 MHz are described below. Various dimensions and specifications for each design are detailed in Table 1 of this document. These specifications are described to provide specific examples and should not be considered as limiting the scope of the inventive concept. For example, variations in notch size, inter-cell spacing, or other minor parameter variations that are sufficiently similar in behavior can be considered equivalent.
[0246] The configuration described below is for circular cell 1552. In some embodiments, a similar configuration (e.g., a similar design approach) may be used for cell 1552 having other cell shapes, such as square, hexagonal, and / or other polygons. In the configuration described below, the plate thickness (e.g., the thickness of the top plate 1557) includes a thickness that achieves the desired center frequency based on the radius (e.g., the effective radius) of cell 1552.
[0247] The algorithmic design method described herein can be applied to both 1D and 2D array configurations of array 150. For example, two cells 1552 across the width of element 1551 refer to a 2×N cell configuration of element 1551 in 1D array 150 (e.g., a 1×N array of element 1551), and a 2×2 cell configuration in 2D array 150 (e.g., a 2×N array of element 1551). As used herein, 1D array 150 has a single row of elements 1551. Each element 1551 consists of a 2D grid of cells 1552. A 2×N cell configuration refers to a 1D array of elements 1551 with two cells 1552 in the azimuth direction and N cells 1552 in the elevation direction. As used herein, 2D array 150 has two or more rows of elements 1551. A 2×2 configuration refers to a 2D array of elements 1551, each consisting of a 2×2 grid of cells 1552.
[0248] In some embodiments, a four-step process can be used to optimize the configuration of CMUT element 1551. First, the spacing of element 1551 is set to half the wavelength of the acoustic wave in the medium at the center frequency of element 1551. Second, the notch is selected based on manufacturing tolerances and typical element separation requirements. Third, various cell 1552 designs are generated, with one, two, or three cells 1552 across the width of element 1551, wherein the design (e.g., size) of the cells maximizes the coverage of the element width. Fourth, the bandwidth of each cell design in step three can be modeled (e.g., based on cell size or other specifications). An optimized cell design can be selected based on a design having the minimum number of cells 1552 on element 1551 (e.g., cells 1552 with the largest area) and an acceptable bandwidth (e.g., sufficiently high bandwidth). In some embodiments, the cutoff value for the acceptable bandwidth can depend on the requirements of the application. In some embodiments, at least 65% or at least 70% of the fractional bandwidth can be selected as the cutoff value (e.g., a minimum bandwidth threshold). The bandwidth of element 1551 can limit the depth resolution of the ultrasound images created using the element. Larger bandwidth allows for better depth resolution. The required bandwidth is determined based on the system's depth resolution requirements. Typical fractional bandwidth for imaging is approximately 50-100%. Bandwidth less than 50% may unacceptably limit depth resolution.
[0249] As shown in the table below, based on the modeling performed by the applicant, for a 3 MHz configuration, a 2-cell width arrangement is the minimum cell design to meet the acceptable bandwidth requirements for dual-mode operation (e.g., imaging and HIFU). For HIFU-only operation, a 1-cell width arrangement can be used. For a 6 MHz design, a 2-cell width arrangement also meets the acceptable bandwidth requirements for dual-mode operation. A 1-cell width arrangement can also be used for HIFU-only operation. For a 10 MHz design, a 2-cell width design meets the acceptable bandwidth requirements for dual-mode operation. A 1-cell width arrangement can also be used for HIFU-only operation.
[0250] Table 1 below also shows the frequency range associated with significant inter-cell interaction problems, based on the applicant's simulated model. It illustrates why it is important to choose an array 150 configuration with a minimized number (e.g., as few as possible) of cells across the width. For example, when considering a 6 MHz operating configuration, the 2-cell design has problems or other limitations in the 2.3 MHz to 4.3 MHz frequency range, thus it can operate effectively over a substantial frequency range around its 6 MHz center frequency. The 3-cell design has inter-cell interaction problems or other limitations between 1.8 MHz and 5.2 MHz, and at 5.8 MHz. This limitation significantly restricts the usable frequency range of the design. Even the 6 MHz center frequency is very close to the "problem frequency" (the frequency with undesirable behavior) that occurs at 5.8 MHz. Therefore, for dual-mode operation, the 2-cell design is superior to the 3-cell design, even with the lower bandwidth.
[0251] Modeling the interactions between cells can be used to determine one or more array parameters, such as quantization performance, but is not required.
[0252] Table 1 below also illustrates the general trade-offs between fractional bandwidth and inter-cell interaction problems or other limitations. Typically, maximizing bandwidth might be considered a design goal. However, this approach may not be optimal for devices used in high-voltage, long-pulse-train applications such as HIFU. In these cases, reduced (e.g., minimum required) bandwidth can be used to minimize inter-cell interaction problems and other limitations.
[0253] The above embodiments should be understood as illustrative examples only; other embodiments are contemplated. Any feature described herein with respect to any embodiment may be used alone or in combination with other features described, and may also be used in combination with one or more features of any other embodiment, or in any combination with any other embodiment. Furthermore, equivalents and modifications not described above may be employed without departing from the scope of the inventive concept defined by the appended claims.
Claims
1. A system for performing medical procedures on a patient, the system comprising: An ultrasound device, comprising an ultrasound array including one or more ultrasound transducers, the ultrasound array being configured to emit ultrasound toward target tissue of a patient. The system is configured as follows: (1) The ultrasound array is operated with a fractional bandwidth in the range of 65% to 100%, and with a ratio of no more than 150% of the maximum plate displacement to the median plate displacement. and / or (2) During the delivery of therapeutic energy, the ultrasound array is operated in a frequency range of 80% to 100% of the center frequency of the one or more ultrasound transducers.
2. The system according to claim 1 and / or any one or more of the other claims herein, wherein during the delivery of energy to generate image data, the system is configured to perform harmonic imaging at a transmit frequency of about 4 MHz and a receive frequency of about 8 MHz.
3. The system according to claim 1 and / or any one or more other claims herein, wherein the system is configured to operate the ultrasonic array at a ratio not exceeding 150% of the maximum plate displacement to the median plate displacement.
4. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasonic array is configured to generate a surface pressure of at least 1 MPa peak-to-peak value over a time period of at least 15 minutes, 20 minutes, or 30 minutes.
5. The system according to claim 4 and / or any one or more other claims herein, wherein the ultrasonic array operates at a frequency of at least 3 MHz, not exceeding 7 MHz, or both.
6. The system according to claim 4 and / or any one or more of the other claims herein, wherein, The ultrasonic array operates with an AC+DC transmission voltage not exceeding 220V.
7. The system according to claim 4 and / or any one or more other claims herein, wherein the ultrasound array operates at at least 65% fractional bandwidth.
8. The system according to claim 1 and / or any one or more other claims herein, wherein the medical procedure includes a diagnostic procedure.
9. The system according to claim 8 and / or any one or more other claims herein, wherein the diagnostic procedure includes imaging and / or other diagnostic analyses of the patient's prostate.
10. The system according to claim 8 and / or any one or more of the other claims herein, wherein the diagnostic procedure includes imaging and / or other diagnostic analysis of the patient’s anatomical locations selected from the group consisting of: prostate; uterus; nasal passages and / or tongue; organs such as bladder, bone, brain, heart, intestine, kidney, liver, lung, skin and / or stomach; and combinations thereof.
11. The system according to claim 8 and / or any one or more of the other claims herein, wherein the diagnostic procedure includes imaging and / or other diagnostic analysis of tissue types selected from the group consisting of: benign prostatic hyperplasia tissue; tumor tissue; tissue associated with arrhythmia; tissue associated with sleep apnea and / or airway obstruction; abnormal and / or other undesirable tissue; and combinations thereof.
12. The system according to claim 1 and / or any one or more other claims herein, wherein the medical procedure includes a treatment procedure.
13. The system according to claim 12 and / or any one or more other claims herein, wherein the treatment procedure includes ablation, stimulation and / or other treatment of the target tissue, wherein the target tissue includes tissue of the patient's prostate.
14. The system according to claim 13 and / or any one or more other claims herein, wherein the system is configured to avoid damage to non-target tissues of the patient.
15. The system according to claim 14 and / or any one or more of the other claims herein, wherein the non-target organization comprises: Urethra wall tissue, seminal vesicle tissue, and / or ejaculatory duct tissue.
16. The system according to claim 12 and / or any one or more of the other claims herein, wherein the treatment procedure comprises ablation, stimulation and / or other treatment of the target tissue, wherein the target tissue comprises tissue located in an anatomical location selected from the group consisting of: prostate; uterus; nasal passages and / or tongue (e.g., to treat sleep apnea); organs such as bladder, bone, brain, heart, intestine, kidney, liver, lung, skin and / or stomach; and combinations thereof.
17. The system according to claim 12 and / or any one or more of the other claims herein, wherein the treatment procedure comprises ablation, stimulation and / or other treatment of the target tissue, wherein the target tissue comprises tissue types selected from the group consisting of: benign prostatic hyperplasia tissue; tumor tissue; tissue associated with arrhythmia; tissue associated with sleep apnea and / or airway obstruction; other abnormal and / or other undesirable tissue; and combinations thereof.
18. The system according to claim 12 and / or any one or more other claims herein, wherein the treatment procedure comprises delivering ultrasound energy to activate the drug and / or other agents; and / or enhance the efficacy of the drug and / or other agents.
19. The system according to claim 1 and / or any one or more of the other claims herein, wherein the system is configured to perform a medical procedure including delivering ultrasound energy to an implant and / or a drug, such as providing power to the implant and / or a drug and / or otherwise modifying the implant and / or a drug.
20. The system according to claim 1 and / or any one or more other claims herein, wherein the medical procedure includes diagnostic and treatment procedures.
21. The system according to claim 20 and / or any one or more other claims herein, wherein the medical procedure includes the diagnosis and treatment of the patient's prostate.
22. The system according to claim 20 and / or any one or more of the other claims herein, wherein the treatment procedure comprises ablation, stimulation and / or other treatment of the target tissue, wherein the target tissue comprises tissue located in an anatomical location selected from the group consisting of: prostate; uterus; nasal passages and / or tongue (e.g., to treat sleep apnea); organs such as bladder, bone, brain, heart, intestine, kidney, liver, lung, skin and / or stomach; and combinations thereof.
23. The system according to claim 20 and / or any one or more of the other claims herein, wherein the treatment procedure comprises ablation, stimulation and / or other treatment of the target tissue, wherein the target tissue comprises tissue types selected from the group consisting of: benign prostatic hyperplasia tissue; tumor tissue; tissue associated with arrhythmia; tissue associated with sleep apnea and / or airway obstruction; other abnormal and / or other undesirable tissue; and combinations thereof.
24. The system according to claim 20 and / or any one or more other claims herein, wherein the medical procedure comprises both imaging and treatment.
25. The system according to claim 24 and / or any one or more of the other claims herein, wherein the imaging and treatment are performed simultaneously, sequentially, or both.
26. The system of claim 24 and / or any one or more other claims herein, wherein the imaging is configured to generate image data, and wherein the treatment is performed based on one or more treatment parameters determined according to the generated image data.
27. The system according to claim 26 and / or any one or more other claims herein, wherein the one or more treatment parameters are determined by the system.
28. The system according to claim 1 and / or any one or more other claims herein, wherein the target tissue comprises tissue of the patient's prostate.
29. The system according to claim 1 and / or any one or more of the other claims herein, wherein the target tissue comprises tissue located at an anatomical location selected from the group consisting of: prostate; uterus; nasal passage and / or tongue; organs such as bladder, bone, brain, heart, intestine, kidney, liver, lung, skin and / or stomach; and combinations thereof.
30. The system according to claim 1 and / or any one or more of the other claims herein, wherein the target tissue comprises tissue of a type selected from the group consisting of: benign prostatic hyperplasia tissue; tumor tissue; tissue associated with arrhythmia; tissue associated with sleep apnea and / or airway obstruction; other abnormal and / or other undesirable tissue; and combinations thereof.
31. The system according to claim 1 and / or any one or more other claims herein, wherein the system is configured to perform system diagnostic procedures, such as diagnostic procedures for evaluating the function of the one or more ultrasonic transducers.
32. The system according to claim 31 and / or any one or more other claims herein, wherein the ultrasound device includes a wall, and wherein the evaluation is based on ultrasound reflections received from the wall.
33. The system according to claim 1 and / or any one or more other claims herein, wherein the system is configured to determine the orientation angle of the ultrasonic array relative to a portion of the ultrasonic device.
34. The system according to claim 33 and / or any one or more other claims herein, wherein the ultrasonic device includes a wall, and wherein the orientation angle is determined based on ultrasonic reflections received from the wall.
35. The system according to claim 33 and / or any one or more other claims herein, wherein the system is configured to generate a 3D image, and wherein the 3D image is enhanced based on a determined orientation angle.
36. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device includes a distal portion, wherein the system is configured and arranged to allow an operator to perform an insertion procedure in which the distal portion of the ultrasound device is inserted by the operator into the patient, and wherein, when the insertion procedure is completed, the ultrasound array is positioned at a desired distance from the target tissue.
37. The system according to claim 36 and / or any one or more other claims herein, wherein the system is configured to generate one or more images of the patient's tissue prior to completion of the insertion procedure, and wherein the ultrasound array is positioned at the desired distance based on the one or more images.
38. The system according to claim 1 and / or any one or more of the other claims herein, wherein the system is configured to generate one or more multidimensional images of a tissue, wherein each multidimensional image includes at least a partial circumferential image of the tissue, wherein the partial circumferential image represents a tissue sector of at least 180°.
39. The system according to claim 38 and / or any one or more other claims herein, wherein the system is configured to create the one or more multidimensional images by manually rotating the ultrasound device by an operator.
40. The system according to claim 38 and / or any one or more other claims herein, wherein the sector comprises a sector of at least 350°.
41. The system according to claim 38 and / or any one or more other claims herein, wherein the system is configured to analyze the one or more multidimensional images and generate at least tissue volume information.
42. The system according to claim 38 and / or any one or more other claims herein, wherein the system is configured to perform diagnostic and / or treatment planning based on the one or more multidimensional images.
43. The system according to claim 38 and / or any one or more other claims herein, wherein the one or more multidimensional images comprise images of most of the patient's prostate, and wherein the multidimensional images are based on ultrasound reflections received when the ultrasound array is positioned within the prostatic urethra.
44. The system according to claim 38 and / or any one or more other claims herein, wherein the ultrasound device includes one or more flexible segments configured to reduce forces encountered during translation within the prostatic urethra or other patient conduit, and wherein the ultrasound device includes one or more components having sufficient torsional strength to allow the ultrasound array to rotate smoothly within the prostatic urethra or other patient conduit.
45. The system of claim 38 and / or any one or more other claims herein, wherein the ultrasonic array comprises a first array and a second array connected by a mechanical component, and wherein the mechanical component is configured to switch between a first state and a second state, wherein in the first state the first array and the second array are flexibly connected, and in the second state the first array and the second array are rigidly connected.
46. The system according to claim 45 and / or any one or more other claims herein, wherein the mechanical component comprises a shape memory component and / or a mechanical linkage.
47. The system according to claim 1 and / or any one or more of the other claims herein, wherein the system is configured to: Automatically identify one or more organizational identifiers; and / or Allows operators to manually identify one or more organizational identifiers. The mark recognition mentioned therein is used for: Automatic positioning and / or repositioning of the ultrasound array; and / or This allows the operator to manually position and / or reposition the ultrasound array.
48. The system according to claim 47 and / or any one or more other claims herein, wherein the tissue marker includes the verumontanum.
49. The system according to claim 47 and / or any one or more of the other claims herein, wherein the system is configured to continuously and / or intermittently image tissue during treatment performed using the ultrasound device, for example to track the progress of treatment and / or ensure that the ultrasound array is in proper position during treatment.
50. The system according to claim 49 and / or any one or more of the other claims herein, wherein the system is configured to track the progress of treatment by monitoring changes in the tissue being treated and / or to ensure that the ultrasound array is in the proper position during treatment.
51. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device includes a distal portion configured for insertion through the urethra, and wherein the system is configured to image the position of bladder tissue and / or within the bladder.
52. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasound device and / or another component of the system is configured to perform a biopsy procedure on the patient.
53. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasound device includes a distal portion configured for insertion through a body cavity, wherein the system is configured to create a set of one or more images during and / or after insertion through the body cavity, and wherein the system is configured to optimize the set of one or more images.
54. The system according to claim 53 and / or any one or more other claims herein, wherein the system is configured to perform the optimization using harmonic imaging.
55. The system according to claim 53 and / or any one or more of the other claims herein, wherein the body cavity includes the prostatic urethra.
56. The system according to claim 1 and / or any one or more other claims herein, wherein the system is configured to determine one or more organizational characteristics.
57. The system according to claim 56 and / or any one or more other claims herein, wherein the system is configured to determine the tissue properties based on the attenuation of ultrasound delivered by the ultrasound array.
58. The system according to claim 56 and / or any one or more of the other claims herein, wherein the system is configured to use determined tissue characteristics to: predict the efficacy of ablation, stimulation and / or other tissue treatments; determine ultrasound delivery parameters for performing ablation, stimulation and / or other tissue treatments; and / or calibrate imaging-related portions, energy delivery-related portions and / or other portions of the system.
59. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device is configured to deliver ultrasound to treat a patient, and wherein the system is configured to monitor the progress of treatment.
60. The system according to claim 59 and / or any one or more other claims herein, wherein the treatment comprises tissue ablation.
61. The system according to claim 59 and / or any one or more of the other claims herein, wherein the system is configured to perform monitoring of treatment progress by simulating heat propagation generated by ultrasound delivery.
62. The system according to claim 61 and / or any one or more of the other claims herein, wherein the system is configured to simulate the heat propagation based on: ultrasonic delivery parameters; parameters of the ultrasonic device; and / or parameters of tissue and other materials near the ultrasonic array during ultrasonic delivery.
63. The system according to claim 61 and / or any one or more of the other claims herein, wherein the system is configured to simulate the heat propagation based on a measurement of tissue attenuation using ultrasound images generated by the system.
64. The system according to claim 63 and / or any one or more of the other claims herein, wherein the system is configured to measure tissue attenuation by analyzing the relationship between signal-to-noise ratio and depth.
65. The system according to claim 64 and / or any one or more of the other claims herein, wherein the analysis comprises analysis of data acquired prior to and during the delivery of ultrasound energy for treatment.
66. The system according to claim 59 and / or any one or more of the other claims herein, wherein the system is further configured to provide a confidence range related to monitoring of treatment progress.
67. The system according to claim 59 and / or any one or more of the other claims herein, wherein, in monitoring the treatment, the system is configured to take into account one or more properties of a tissue selected from the group consisting of: absorption; perfusion; backscattering; temperature; elasticity; displacement; intensity distribution; other tissue properties that may change during the treatment; and combinations thereof.
68. The system according to claim 59 and / or any one or more other claims herein, wherein the system is configured to monitor one or more parameters of the ultrasound transducer, and wherein the system is configured to perform monitoring of treatment progress based on the ultrasound transducer parameters.
69. The system according to claim 59 and / or any one or more of the other claims herein, wherein the system is configured to collect image data, and wherein the system is configured to perform monitoring of treatment progress based on the collected image data.
70. The system according to claim 69 and / or any one or more of the other claims herein, wherein the system uses local image intensity statistics to assess tissue changes over time.
71. The system according to claim 70 and / or any one or more other claims herein, wherein the collected image data includes images acquired before, during, and after treatment.
72. The system according to claim 70 and / or any one or more other claims herein, wherein the local image intensity statistical technique comprises: Extract local image statistical information.
73. The system according to claim 72 and / or any one or more other claims herein, wherein the local image statistics include: Local mean; local standard deviation; local extrema; local kurtosis; local skewness; and / or local higher-order standardized moments.
74. The system according to claim 70 and / or any one or more other claims herein, wherein the image intensity statistical technique comprises: Principal component analysis; singular value decomposition; and / or other feature extraction and / or selection techniques.
75. The system according to claim 59 and / or any one or more of the other claims herein, wherein monitoring of treatment comprises: Capture one or more images in the first set before treatment; Capture a second set of one or more images after treatment; And combining and / or comparing one or more images from the first group with one or more images from the second group.
76. The system according to claim 75 and / or any one or more of the other claims herein, wherein the system is configured to produce visual output, wherein tissue properties representing therapeutic effects are highlighted, color-coded, segmented and / or otherwise graphically distinguished.
77. The system according to claim 1 and / or any one or more of the other claims herein, wherein the system is configured to perform a treatment procedure including the delivery of ultrasound, and wherein the system is further configured to generate a treatment log representing treatment parameters and / or treatment results.
78. The system according to claim 77 and / or any one or more other claims herein, wherein the treatment log includes a comparison of tissue intended to be treated with tissue actually treated.
79. The system according to claim 77 and / or any one or more other claims herein, wherein the system is configured to generate the treatment log prior to completion of the treatment procedure.
80. The system according to claim 77 and / or any one or more other claims herein, wherein the treatment log includes analysis of pressure zones; Ablated tissue volume; The ablated tissue volume relative to the total tissue volume; the stimulated tissue volume; and / or the stimulated tissue volume relative to the total tissue volume.
81. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasound device includes a catheter device.
82. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device comprises one, two, three or more devices selected from the group consisting of: catheter devices; surgical devices; devices configured for insertion via a laparoscopic guide; devices configured for insertion via a vascular guide; devices configured for insertion via an endoscope; devices configured for insertion via a surgical incision; and combinations thereof.
83. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device includes a distal portion configured and arranged to be inserted into and / or pass through the patient's urethra.
84. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device comprises a distal portion configured and arranged to be inserted into and / or through one or more lumens, openings and / or other body tubes selected from the group consisting of: urethra; vaginal canal; blood vessel; catheter; airway; intestine; larynx; esophagus; oral cavity; anus; ear; nostril; and combinations thereof.
85. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasonic device further comprises a thermal insulation layer surrounding at least a portion of the ultrasonic array.
86. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasound device includes an expandable anchoring element configured to anchor the ultrasound array relative to the target tissue.
87. The system according to claim 86 and / or any one or more other claims herein, wherein the expandable anchor comprises an inflatable airbag.
88. The system according to claim 86 and / or any one or more other claims herein, wherein the expandable anchor is configured to expand in the patient's bladder.
89. The system according to claim 86 and / or any one or more other claims herein, wherein the ultrasound device includes a removable sleeve, and wherein the removable sleeve includes the expandable anchor.
90. The system according to claim 89 and / or any one or more other claims herein, wherein the removable sleeve comprises a thermal insulation layer.
91. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasonic device comprises a rigid segment and one or more flexible segments.
92. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasound device comprises a proximal portion, a distal portion, and a lumen extending from the proximal portion to the distal portion.
93. The system according to claim 92 and / or any one or more of the other claims herein, wherein the lumen is configured and arranged to slidably receive an elongated device comprising a diagnostic device, a therapeutic device, or both.
94. The system according to claim 93 and / or any one or more other claims herein, wherein the elongated device comprises a cystoscope and / or a photoacoustic device.
95. The system according to claim 92 and / or any one or more other claims herein, wherein the system is configured to deliver fluid through the lumen to achieve and / or enhance acoustic coupling between the ultrasound array and the target tissue.
96. The system according to claim 92 and / or any one or more other claims herein, wherein the system is configured to deliver fluid through the lumen to cool at least the ultrasonic array.
97. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device comprises a proximal portion and a lumen extending from said proximal portion, and wherein delivery of fluid into said lumen is configured to perform a function selected from the group consisting of: To achieve and / or enhance acoustic coupling between the ultrasound array and the target tissue; Change the flexibility of the ultrasonic device; Change the straightness of the ultrasonic device; and their combinations.
98. The system according to claim 1 and / or any one or more other claims herein, wherein the system is configured to reduce the clamping force applied to the ultrasonic device.
99. The system according to claim 98 and / or any one or more other claims herein, wherein the system is configured to reduce the clamping force by: delivering one or more ultrasonic pulses; causing one or more portions of the ultrasonic device to vibrate; or both.
100. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasonic device is configured to deliver at least 100 W / cm². 2 The energy is used to treat prostate tissue, tumor tissue, and / or other tissues.
101. The system according to claim 1 and / or any one or more other claims herein, further comprising a guide device configured to be inserted into a patient and slidably receive the ultrasound device.
102. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device is configured to be introduced through the lumen of a device selected from the group consisting of: a guide catheter such as a guide catheter; a Freel catheter; a sheath; a laparoscopic port; an endoscope; and combinations thereof.
103. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device is configured to be inserted via a means configured to be inserted through the bulbar urethra.
104. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasound device includes a vibrating element configured to reduce the insertion force encountered when the ultrasound device is translated through the body tube of a patient.
105. The system according to claim 1 and / or any one or more of the other claims herein, wherein the ultrasonic device includes a distal portion comprising a coating.
106. The system according to claim 105 and / or any one or more other claims herein, wherein the coating comprises PTFE and / or other friction-reducing coatings.
107. The system according to claim 1 and / or any one or more other claims herein, wherein the one or more ultrasonic transducers comprise one or more CMUT transducers.
108. The system according to claim 1 and / or any one or more other claims herein, wherein the one or more ultrasonic transducers comprise one or more piezoelectric transducers.
109. The system according to claim 1 and / or any one or more other claims herein, wherein the one or more ultrasonic transducers comprise one or more CMUT transducers and one or more piezoelectric transducers.
110. The system according to claim 1 and / or any one or more other claims herein, wherein the system includes one or more protection diodes configured to prevent damage to the one or more ultrasonic transducers.
111. The system according to claim 110 and / or any one or more other claims herein, wherein each of the one or more protection diodes has an adjustable voltage limit.
112. The system according to claim 110 and / or any one or more other claims herein, wherein the one or more protection diodes are configured to provide high voltage spike protection for the one or more ultrasonic transducers.
113. The system according to claim 112 and / or any one or more other claims herein, wherein the one or more protection diodes are configured to provide high-voltage spike protection against cascade breakdown of the one or more ultrasonic transducers.
114. The system according to claim 110 and / or any one or more other claims herein, wherein the system includes a feedback control system that modulates the amplitude output and / or phase output of the one or more ultrasonic transducers.
115. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasonic array comprises a plurality of ultrasonic arrays, each ultrasonic array comprising one or more ultrasonic transducers.
116. The system according to claim 115 and / or any one or more of the other claims herein, wherein the plurality of ultrasound arrays are configured and arranged to ablate, stimulate and / or otherwise treat tissue volumes of at least 10 cc, such as at least 20 cc, 40 cc, 80 cc, 120 cc and / or 150 cc.
117. The system according to claim 115 and / or any one or more other claims herein, wherein the ultrasound device is configured to guide and deliver ablation, stimulation and / or other therapeutic energy to tissue via an image provided by the ultrasound device.
118. The system according to claim 117 and / or any one or more other claims herein, wherein the system is configured to deliver ablation energy from the prostatic urethra.
119. The system according to claim 115 and / or any one or more of the other claims herein, wherein the plurality of arrays are configured to independently create images of the patient, and the created images are used to provide: guidance information; diagnostic information; and / or treatment planning information.
120. The system according to claim 115 and / or any one or more other claims herein, further comprising a set of electrical connections and multiplexers, wherein the multiplexers are configured to selectively connect the electrical connections to each of the plurality of ultrasound arrays.
121. The system according to claim 115 and / or any one or more other claims herein, wherein the first ultrasonic array is configured to emit ultrasonic waves, and the second ultrasonic array is configured to receive the emitted ultrasonic waves, and wherein the received ultrasonic waves are used to detect and / or measure the relative position between the first ultrasonic array and the second ultrasonic array.
122. The system according to claim 121 and / or any one or more other claims herein, wherein the first ultrasonic array and the second ultrasonic array each comprise an array of at least 128 CMUT ultrasonic transducers.
123. The system according to claim 121 and / or any one or more other claims herein, wherein the relative position between the first ultrasound array and the second ultrasound array is used to determine a delay, wherein the delay is used to create an image using both the first ultrasound array and the second ultrasound array.
124. The system according to claim 121 and / or any one or more other claims herein, wherein the relative position between the first ultrasound array and the second ultrasound array is used to determine a delay, wherein the delay is used to deliver ablation, stimulation and / or other therapeutic energy to tissue using both the first ultrasound array and the second ultrasound array.
125. The system according to claim 1 and / or any one or more other claims herein, wherein each of the one or more ultrasound transducers of the ultrasound array is configured to switch between imaging mode and treatment mode in less than 6 seconds, 100 milliseconds, 10 milliseconds and / or 1 millisecond.
126. The system according to claim 125 and / or any one or more other claims herein, wherein the system includes a switching assembly configured to perform switching of the ultrasound transducer between the imaging mode and the treatment mode.
127. The system according to claim 126 and / or any one or more other claims herein, wherein the switching assembly comprises a switch having a resistance of no more than 3 ohms per channel, a capacitance of no more than 50 pF per channel, or both.
128. The system of claim 126 and / or any one or more other claims herein, wherein the switching assembly comprises an imaging drive circuit, a therapeutic energy drive circuit, and a set of switches configured to switch between connecting the one or more ultrasound transducers to the imaging drive circuit and the therapeutic energy drive circuit.
129. The system according to claim 128 and / or any one or more other claims herein, wherein the set of switches comprises MEMS switches and / or low-resistance, low-capacitance switches.
130. The system according to claim 128 and / or any one or more other claims herein, wherein the imaging drive circuitry includes a set of receiving amplifiers, wherein the receiving amplifiers are positioned proximal to and adjacent to each of the set of switches.
131. The system according to claim 128 and / or any one or more other claims herein, wherein the switching assembly further comprises a set of biasers, each biaser being located distal to each switch of the set of switches and configured to provide DC bias to the associated ultrasonic transducer.
132. The system according to claim 126 and / or any one or more other claims herein, wherein the switching assembly includes an adjustable overvoltage protection circuit.
133. The system according to claim 126 and / or any one or more other claims herein, wherein the therapeutic energy drive circuit includes an overshoot protection circuit.
134. The system according to claim 126 and / or any one or more other claims herein, wherein the set of switches comprises a corresponding set of pull-down resistors, each resistor having a resistance of at least 5 kOhm and / or at least 1 MOhm, and configured to dissipate unwanted voltage present at each switch.
135. The system according to claim 126 and / or any one or more other claims herein, wherein the switching assembly is configured to operably connect and disconnect each ultrasonic element from a bias voltage source.
136. The system according to claim 135 and / or any one or more other claims herein, wherein the switching assembly is configured to test for a short circuit by connecting an ultrasonic element to the bias voltage source and measuring the current delivered by the bias voltage source.
137. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasonic transducers of the ultrasonic array are arranged for both forward-viewing and lateral-viewing configurations.
138. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasonic device further comprises an acoustic lens.
139. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasound device further comprises a handle.
140. The system according to claim 139 and / or any one or more other claims herein, further comprising a user interface, wherein the handle comprises at least a portion of the user interface.
141. The system according to claim 139 and / or any one or more other claims herein, wherein the handle includes an alarm element comprising a tactile transducer.
142. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasonic device further comprises a cooling module.
143. The system according to claim 142 and / or any one or more other claims herein, wherein the cooling module is mechanically coupled to the ultrasonic array and / or otherwise positioned near the ultrasonic array.
144. The system according to claim 142 and / or any one or more other claims herein, wherein the cooling module is configured to cool the ultrasound array, the tissue near the ultrasound array and / or the tissue being treated, or both.
145. The system according to claim 142 and / or any one or more other claims herein, wherein the cooling module comprises a thermoelectric cooling module.
146. The system according to claim 142 and / or any one or more other claims herein, wherein the cooling module comprises a solid-state cooling module.
147. The system according to claim 142 and / or any one or more other claims herein, wherein the cooling module comprises a cooling element and a solid heat conductor configured to conduct heat away from the cooling element.
148. The system according to claim 142 and / or any one or more other claims herein, wherein the cooling module includes a fluid path located within the ultrasonic device.
149. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasound device comprises a sensor module including one or more sensors.
150. The system according to claim 149 and / or any one or more other claims herein, wherein the one or more sensors comprise one or more temperature sensors.
151. The system according to claim 149 and / or any one or more other claims herein, wherein the one or more sensors comprise one or more sensors selected from the group consisting of: temperature sensors; pressure sensors; strain gauges; accelerometers; gyroscopes; inertial measurement units; physiological sensors; GPS sensors; and combinations thereof.
152. The system according to claim 149 and / or any one or more other claims herein, wherein the sensor module is configured to record parameters of target tissue and / or non-target tissue.
153. The system according to claim 152 and / or any one or more of the other claims herein, wherein the non-target tissue parameter comprises a parameter selected from the group consisting of: temperature; pressure; and combinations thereof.
154. The system according to claim 149 and / or any one or more other claims herein, wherein the sensor module includes at least one sensor configured for articulation.
155. The system according to claim 154 and / or any one or more other claims herein, wherein the at least one articulated sensor is configured to rotate and record data while avoiding applying force to tissue near the at least one articulated sensor.
156. The system according to claim 1 and / or any one or more other claims herein, wherein the system includes a console comprising an ultrasound module for providing drive signals to the ultrasound array.
157. The system according to claim 156 and / or any one or more other claims herein, wherein the ultrasound module includes a dual-frequency signal generator.
158. The system according to claim 157 and / or any one or more other claims herein, wherein the ultrasound module is configured to: generate a drive signal of a first frequency for delivering ultrasound to tissue at a distance not exceeding D1 from the ultrasound array; and generate a drive signal of a second frequency for delivering ultrasound to target tissue at a distance of at least D2 from the ultrasound array, wherein D2 is equal to or greater than D1, and wherein the first frequency is higher than the second frequency.
159. The system according to claim 158 and / or any one or more other claims herein, wherein the first frequency comprises a frequency of at least 4.5 MHz, wherein the second frequency comprises a frequency of no more than 3.5 MHz, wherein D1 comprises a distance of no more than 25 mm, and wherein D2 comprises a distance of at least 25 mm.
160. The system according to claim 159 and / or any one or more other claims herein, wherein the first frequency comprises a frequency not exceeding 5.5 MHz and / or the second frequency comprises a frequency of at least 2.5 MHz.
161. The system according to claim 159 and / or any one or more other claims herein, wherein D1 comprises a distance of at least 0.001 mm and / or wherein D2 comprises a distance of no more than 50 mm.
162. The system according to claim 156 and / or any one or more other claims herein, wherein the ultrasonic module includes a tuning circuit operating at one or more frequencies of at least 1 MHz and / or one or more frequencies not exceeding 10 MHz.
163. The system according to claim 156 and / or any one or more other claims herein, wherein the ultrasound module comprises two electronically switchable tuning circuits configured to provide operation at multiple different frequencies.
164. The system according to claim 163 and / or any one or more other claims herein, wherein the ultrasound module includes relays and / or other switching components configured to switch between components of the two electronically switchable tuning circuits.
165. The system according to claim 163 and / or any one or more other claims herein, wherein one or more components of the first tuning circuit in the two electronically switchable tuning circuits are shared by the second tuning circuit in the two electronically switchable tuning circuits.
166. The system according to claim 163 and / or any one or more other claims herein, wherein the ultrasound module is configured to operate a first group of one or more transducers of the ultrasound array at a first frequency and simultaneously operate a second group of one or more transducers of the ultrasound array at a second frequency different from the first frequency.
167. The system according to claim 1 and / or any one or more other claims herein, wherein the ultrasound device includes an identification component, and wherein the console is configured to receive information from the identification component.
168. The system according to claim 167 and / or any one or more other claims herein, wherein the identification component includes RFID.
169. The system according to claim 167 and / or any one or more other claims herein, wherein the information received from the identification component includes manufacturing information, calibration information, and / or diagnostic information of the ultrasound device.
170. The system according to claim 167 and / or any one or more other claims herein, wherein information received from the identification component is used by the console to confirm that the ultrasound device is correctly instructed, correctly configured, and / or otherwise ready for use.
171. The system according to claim 1 and / or any one or more other claims herein, wherein the system includes a cooling device.
172. The system according to claim 171 and / or any one or more other claims herein, wherein the ultrasonic device includes a cooling module configured and arranged to receive cooling fluid supplied by the cooling device.
173. The system according to claim 172 and / or any one or more other claims herein, wherein the cooling module includes one or more fluid paths located within the ultrasonic device, wherein the one or more fluid paths receive cooling fluid provided by the cooling device.
174. The system according to claim 1 and / or any one or more of the other claims herein, further comprising a processing unit including a processor and a memory storage element coupled to the processor, wherein the memory storage element stores instructions for the processor to execute an algorithm.
175. The system according to claim 174 and / or any one or more other claims herein, further comprising a console, wherein the console includes at least a portion of the processing unit.
176. The system according to claim 174 and / or any one or more other claims herein, wherein the ultrasound device includes at least a portion of the processing unit.
177. The system according to claim 174 and / or any one or more other claims herein, wherein the algorithm includes an artificial intelligence algorithm.
178. The system according to claim 174 and / or any one or more of the other claims herein, wherein the system is configured to generate a multidimensional image of a tissue, and wherein the algorithm comprises an artificial intelligence algorithm or other algorithm, the algorithm being configured to: Identify tissue areas to avoid treatment; and / or Recommended tissue areas for treatment.
179. The system according to claim 174 and / or any one or more of the other claims herein, wherein the algorithm includes an artificial intelligence algorithm or other algorithm configured to evaluate image data to maintain a focal spot for delivering ablation, stimulation and / or other therapeutic energy.
180. The system according to claim 179 and / or any one or more other claims herein, wherein the algorithm is configured to modify the delay of the signal delivered to the ultrasonic transducer to maintain the focal spot.
181. The system according to claim 174 and / or any one or more other claims herein, wherein the algorithm includes an artificial intelligence algorithm or other algorithm configured to identify one or more ablation modes that have other undesirable effects when reducing edema or delivering ablation energy to the target tissue.
182. The system according to claim 174 and / or any one or more other claims herein, wherein the processing unit further comprises at least one application configured to be provided and / or executed by the system.
183. The system according to claim 1 and / or any one or more other claims herein, wherein the system includes a user interface.
184. The system according to claim 183 and / or any one or more other claims herein, further comprising a console, wherein the console includes at least a portion of the user interface.
185. The system according to claim 183 and / or any one or more other claims herein, wherein the ultrasound device includes at least a portion of the user interface.
186. The system according to claim 183 and / or any one or more other claims herein, wherein the user interface includes an alarm element.
187. The system according to claim 186 and / or any one or more other claims herein, wherein the alarm element comprises a tactile transducer positioned within the ultrasonic device.
188. The system according to claim 183 and / or any one or more other claims herein, wherein the user interface comprises a touchscreen display and / or other display.
189. The system according to claim 183 and / or any one or more other claims herein, wherein the user interface is configured as a graphical user interface.
190. The system according to claim 1 and / or any one or more other claims herein, further comprising one or more functional elements.
191. The system according to claim 190 and / or any one or more other claims herein, wherein the one or more functional elements comprise one or more sensors and / or one or more transducers.
192. The system according to claim 190 and / or any one or more other claims herein, wherein the functional element includes one or more vacuum ports located in the vicinity of the ultrasonic array.
193. The system according to claim 192 and / or any one or more other claims herein, wherein the one or more vacuum ports are configured to: prevent movement of the ultrasound array; maintain a portion of the ultrasound device in contact with tissue; or both.
194. The system according to claim 1 and / or any one or more other claims herein, further comprising a robotic manipulator configured to robotically manipulate the ultrasound device and / or one or more other components of the system.
195. The system according to claim 194 and / or any one or more other claims herein, wherein the robotic manipulator is configured to rotate the ultrasound device to create 360° images of the tissue and / or images of the tissue at least greater than 180°.
196. The system according to claim 1 and / or any one or more other claims herein, further comprising a pharmaceutical agent containing one or more agents.
197. The system according to claim 1 and / or any one or more other claims herein, further comprising a network and at least one server.
198. The system according to claim 1 and / or any one or more other claims herein, further comprising a second medical device.
199. The system according to claim 1 and / or any one or more other claims herein, further comprising a second imaging device, the second imaging device comprising at least one imaging device.
200. The system according to claim 199 and / or any one or more of the other claims herein, wherein the second imaging device comprises one, two or more imaging devices selected from the group consisting of: an ultrasound imaging device; a fluorescence microscope and / or other X-ray imaging device; a magnetic resonance imaging (MRI) device; a CT scanner; an optical coherence tomography (OCT) imaging device; a transesophageal echo imaging device; a transrectal imaging device; a catheter-based imaging device; a cystoscope; a photoacoustic imaging device; an impedance-based imaging device; and combinations thereof.
201. The system according to claim 199 and / or any one or more other claims herein, wherein the system is configured to generate a first set of one or more images using the ultrasound device and to generate a second set of one or more images using the second imaging device, and wherein the system is further configured to compare and / or combine the first set of images with the second set of images.
202. The system according to claim 1 and / or any one or more other claims herein, further comprising an accessory device, the accessory device including at least one accessory device.
203. The system according to claim 202 and / or any one or more other claims herein, wherein the accessory device includes a positioning device configured to establish one or more reference points for the ultrasound equipment to create images, deliver therapeutic energy, or both.
204. The system according to claim 202 and / or any one or more other claims herein, wherein the accessory device comprises a balloon catheter configured to dilate the urethral passage.
Citation Information
Patent Citations
Medical device with CMUT array and solid state cooling, and associated methods and systems
US11154730B2
Medical device with CMUT array and solid state cooling, and associated methods and systems
US11998766B2
Medical device with CMUT array and solid state cooling, and associated methods and systems
US12508448B2
Medical device with CMUT array and solid state cooling, and associated methods and systems
US20190076674A1
Tissue interface system
US20230414299A1
